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Avant propos 
 
 
Le format de présentation de cette thèse correspond à une recommandation 
de la spécialité Maladies Infectieuses et Microbiologie, à l’intérieur du 
Master des Sciences de la Vie et de la Santé qui dépend de l’Ecole 
Doctorale des Sciences de la Vie de Marseille. Le candidat est amené à 
respecter des règles qui lui sont imposées et qui comportent un format de 
thèse utilisé dans le Nord de l’Europe et qui permet un meilleur rangement 
que les thèses traditionnelles. Par ailleurs, la partie introduction et 
bibliographie est remplacée par une revue envoyée dans un journal afin de 
permettre une évaluation extérieure de la qualité de la revue et de permettre 
à l’étudiant de commencer le plus tôt possible une bibliographie exhaustive 
sur le domaine de cette thèse. Par ailleurs, la thèse est présentée sur article 
publié, accepté ou soumis associé d’un bref commentaire donnant le sens 
général du travail. Cette forme de présentation a paru plus en adéquation 
avec les exigences de la compétition internationale et permet de se 
concentrer sur des travaux qui bénéficieront d’une diffusion internationale. 
 
 
Professeur Didier Raoult 
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RESUME 
Les abcès cérébraux sont des infections potentiellement mortelles, entraînant souvent 
des séquelles graves. La prise en charge médicale en reste empirique en raison d’un manque 
de connaissance approfondie des microorganismes responsables de cette condition. Dans la 
plupart des laboratoires microbiologiques, le diagnostic d’abcès cérébral est basé sur la 
culture du pus recueilli chirurgicalement. Malheureusement, cette procédure a de 
nombreuses limites et ne permet l’identification que d’une petite partie de la population 
microbienne en cause. L’amplification par PCR et le séquençage du gène codant la fraction 
16S de l’ADN ribosomal ont récemment été utilisées pour surmonter les limites de la 
culture, et ont été démontré leur efficacité dans la documentation des infections 
bactériennes. Malheureusement, cette procédure présente un degré de discrimination limité 
en cas d’infection polymicrobienne. Des études métagénomiques de flores complexes de 
l’homme, basées sur une combinaison de PCR, clonage et séquençage des produits de PCR 
se sont avérées utiles pour évaluer la diversité bactérienne des flores dentaires, vaginales et 
intestinales.  
Nous avons appliqué cette technique à des échantillons d’abcès cérébral pour étudier la 
flore associée à cette maladie. Dans une première étape, nous avons réalisé une enquête en 
utilisant la culture et les techniques moléculaires. Le but de cette étude était d’analyser et 
d’évaluer les bactéries de la flore responsable des abcès cérébraux, en comparant la culture à 
trois techniques moléculaires basées sur le gène 16S rDNA, incluant le séquençage direct, le 
clonage suivi de séquençage par méthode de Sanger, et le séquençage direct des produits de 
PCR par pyroséquençage. Cette enquête a déterminé que la variété des espèces bactériennes 
associée aux abcès cérébraux est beaucoup plus grande que précédemment décrite, et inclut 
de nombreuses bactéries anaérobies et des bactéries incultivables de la flore buccale. Cette 
étude préliminaire a identifié 49 agents bactériens différents, et a permis l’identification de 
27 bactéries jamais détectées auparavant dans des abcès du cérébraux, dont 15 n’avaient 
jamais été cultivées. Un tel nombre d’espèces bactériennes impliquées dans les abcès 
cérébraux a motivé l’étude de 51 nouveaux spécimens dans le but de décrire plus en détail la 
flore associée aux abcès cérébraux en fonction de leurs étiologies.  
Ainsi, nous avons effectué une analyse métagénomique, basé sur le gène 16S rDNA, de 
51 patients ayant développé un abcès cérébral. Notre stratégie a été beaucoup plus 
discriminatoire et a permis à l’identification d’un plus grand nombre de bactéries que la 
culture et l’amplification et le séquençage direct de l’ANRr 16S. La combinaison des 
données de 71 patients (20 de la première étude et 51 de la deuxième étude) a permis 
l’identification de plusieurs associations à l’aide de la méthode de data mining.  
En outre, notre étude a permis l’identification de deux nouvelles bactéries, la première 
étant une nouvelle espèce de genre Staphylococcus (Staphylococcus massiliensis) et la 
seconde étant une bactérie anaérobie qui représente une nouvelle espèce dans un nouveau 
genre au sein du phylum des Bacteroidetes (Phocaeicola abscesses). En outre, nous avons 
décrit deux cas inhabituels d’abcès du cerveau, à Mycoplasma hominis après curetage 
utérin, et à Nocardia carnea chez un greffé rénal. Malgré les limites inhérentes à la 
procédure de clonage, nos résultats suggèrent que le clonage et le séquençage de gène 
DNAr 16S est une méthode très performante pour identifier les agents bactériens associés 
aux abcès cérébraux. 
 
Mots-clés: abcès cérébral, identification moléculaire, PCR, gène 16S rDNA, clonage de 
gènes 16S rDNA. 
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ABSTRACT  
Brain abscess is a life-threatening infection with frequent serious sequelae. The 
medical management remains empirical due to a lack of comprehensive knowledge of 
the microorganisms responsible for this condition. In most microbiology laboratories 
the diagnosis of brain abscess is based on culture from pus collected surgically. 
Unfortunately, this procedure has many limitations and reveals only a small portion of 
the true microbial population. PCR-amplified 16S rDNA sequencing has recently been 
used to overcome the limitations of culture-based bacterial detection in brain abscess 
pus, and it was demonstrated to be effective in the documentation of monomicrobial 
infections. Unfortunately, this procedure failed to discriminate among polymicrobial 
floras.  
Metagenomic studies of complex human floras using a combination of                     
16S rDNA PCR and cloning-sequencing of PCR products proved useful to evaluate 
the bacterial diversity of dental, vaginal and intestinal floras. Thus, we applied this 
technique to brain abscess samples to study the flora associated with this condition. In 
a first step, we performed an investigation using culture and molecular techniques. The 
purpose of this investigation was to analyze and evaluate the bacterial flora responsible 
for brain abscess by comparing standard culture technique to three techniques using 
16S rDNA amplification, that is, direct sequencing, multiple sequencing following 
cloning, and multiple sequencing via high throughput pyrosequencing. This 
investigation has determined that the variety of brain abscess-associated bacterial 
species is much larger than previously reported, and it includes many anaerobes and 
uncultured bacteria from the oral cavity flora. This preliminary study identified                 
49 distinct brain abscess bacterial agents, and enabled the identification of 27 bacteria 
never detected before in brain abscess, 15 of which were uncultured.  
Such a high number of bacterial species involved in brain abscess prompted the 
study of 51 new specimens in an effort to describe further the flora associated with 
brain abscesses and their etiologies. Thus, we performed a 16S rDNA-based 
metagenomic analysis of cerebral abscesses from 51 patients. Our strategy was 
significantly more discriminatory and enabled the identification of greater number of 
bacterial taxa, than culture and conventional 16S rDNA PCR/sequencing, respectively. 
The combination of data from 71 patients (20 from the first study and 51 from the 
second study) enabled the identification of several associations using the data mining 
analysis. Also, these studies permitted the identification of two novel bacteria, the first 
being a novel Staphylococcus species (Staphylococcus massiliensis) and the second 
being a novel anaerobic bacterium that represents a novel species in a new genus 
within the phylum Bacteroidetes (Phocaeicola abscesses). In addition, we reported 
tow unusual cases of brain abscess, the first case was a Mycoplasma hominis brain 
abscess following uterus curettage and the second case was a Nocardia carnea 
infection in a kidney transplant recipient patient.   
Despite limitations inherent to the cloning procedure, our results suggest that 
cloning and sequencing of PCR-amplified 16S rDNA is a highly valuable method to 
identify bacterial agents of brain abscesses.  
 
Key-words: brain abscess, molecular identification, 16S rRNA gene PCR, 16S rRNA 
gene cloning.  
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INTRODUCTION 
Brain abscess is a life-threatening condition resulting from a focal 
intracerebral infection that begins as a localized area cerebritis and 
develops into a collection of pus surrounded by a well-vascularised capsule 
[1]. Brain abscesses arise secondary to haematogenous dissemination from 
a distant focus [2, 3], by direct extension from a contiguous suppurative 
focus (paranasal sinuses, middle ear, mastoids) [1-3] or when the integrity 
of the central nervous system is compromised (trauma or neurosurgery) [4]. 
In 20-30 % of cases, no source can be identified [1, 3]. Brain abscesses 
occur at all ages, more frequently in men than in women [4-6]. 
Computerized tomography and magnetic resonance enabled an earlier and 
more accurate diagnosis [7-9]. Despite advancements in diagnostic and 
neurosurgical procedures, a mortality of 8-32 % attributable to brain 
abscess was reported [6, 9-11] and sequelae were observed in 9-36 % of the 
patients [4, 11, 12]. Presently, the characterization of the bacterial 
pathogens in brain abscesses is principally obtained from culture of pus 
collected by neurosurgical drainage [9, 13]. Unfortunately, this procedure 
has many limitations and reveals only a small portion of the true microbial 
population. Pus from brain abscesses has been reported to be sterile in 9-
63 % of cases [12, 14]. In recent years, molecular methods have 
increasingly been used to detect microorganisms in various clinical 
samples, including those from patients with central nervous system 
infections. A bacterial species can be identified by comparing its DNA 
sequence to that of other bacteria in databases, notably the GenBank 
database [15]. Sequencing of 16S rDNA PCR amplified was used in few 
studies to detect bacteria in pus of brain abscesses [16-18]. The results 
showed that, 16S rDNA amplification and sequencing offer a more rapid 
and accurate identification than that obtained with standard phenotypic 
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methods that depend on bacterial growth [14, 16, 19]. Unfortunately, this 
procedure fails to discriminate among mixed flora [14]. Metagenomic 
studies of complex human floras using a combination of 16S rDNA PCR 
and cloning-sequencing of PCR products proved useful to evaluate the 
bacterial diversity of dental, vaginal and intestinal floras [20-26]. We 
applied this approach on brain abscess specimens to identify the bacterial 
diversity associated with this condition. The results obtained were 
compared to culture results. Our results showed that the flora associated 
with brain abscess is mostly complex and significantly more variable than 
that characterized by culture or PCR amplified product sequencing.  
 11 
 
 
REVIEW 
 
 
Diagnosis of Brain Abscesses 
 
 
 
Mouhamad Al Masalma,
 
Didier Raoult, Pierre-Edouard Fournier *
 
 
 
 
 
 
Pôle des Maladies Infectieuses, Assistance Publique-Hôpitaux de Marseille 
and Unité des Rickettsies et Maladies Infectieuses Emergentes UMR 
CNRS-IRD 6236, IFR 48, Université de la Méditerranée, Marseille, France 
 
 
 
 12 
 
 13 
 
 
 
 
 
 
Diagnosis of Brain Abscesses 
 
 
 
 
Mouhamad Al Masalma1,
 
 Didier Raoult1,2, 
 
Pierre-Edouard Fournier1,2
 
 
 
 
 
 
 
 
1 Fédération de Microbiologie Clinique, Hôpital de la Timone, Rue Saint-
Pierre, 13385 Marseille cedex 5, Marseille 
 
2  Unité des Rickettsies et Maladies Infectieuses Emergentes, UMR CNRS-
IRD 6236, Faculté de Médecine, Université de la Méditerranée, 
Marseille, France 
 
 
 
 
 
 
 
 
 
Corresponding author: Pierre-Edouard Fournier, Unité de Recherche sur les 
Maladies infectieuses et Tropicales Emergentes, Faculté de Médecine,             
27 Bd Jean Moulin, 13385 Marseille, France. Tel : +33 491 385 517 ;             
fax : +33 491 387 772 ; email : pierre-edouard.fournier@univmed.fr  
 
 
 
 
 
 14 
 
 
 
 
 
 15 
Abstract  
 
 Brain abscess is a life-threatening infection with frequent serious 
sequelae. Microorganisms that cause brain abscess can reach the brain from 
various sources and the causative microbial flora is differentially 
distributed according to the abscess aetiology. Culture-based methods 
present many limitations and do not enable an exhaustive documentation of 
the bacterial flora. Conventional 16S rRNA amplification and sequencing, 
although offering a more rapid and accurate identification than culture, 
present the major drawback of having a limited discriminatory power 
among taxa in complex floras. In contrast, 16S rRNA amplification 
followed by cloning and sequencing demonstrated to be particularly suited 
to the study of complex microbiotas. When applied to brain abscess, this 
strategy has resulted in an improved identification of the bacterial diversity, 
in particular in infections of dental or sinusal origins, and has highlighted 
the role of uncultured and fastidious bacteria.   
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Introduction 
 Brain abscess is a focal, intracerebral infection that begins as a 
localized area of cerebritis and develops into a collection of pus surrounded 
by a well-vascularized capsule (40). The medical management of this 
condition remains mostly empirical because of a lack of comprehensive 
knowledge of the causative microorganisms. Bacteria are the main 
recognized agents, but fungi and parasites may be involved. The infection 
may be primary in case of a penetrating trauma or a complication of brain 
surgery, or secondary to a paranasal sinusitis, an otogenic or dental 
infection, or a metastatic spread during a bacteremia (6,26,40,69).                       
Brain abscesses occur at all ages, more frequently in men than in women 
(6,49,56). In the past 20 years, major advances in the diagnosis and 
management of brain abscess have contributed to the decrease in associated 
morbidity and mortality (40). These include progresses in radiographic 
scanning, the availability of new antimicrobials, and the development               
of novel surgical techniques. However, brain abscesses remain associated 
with a high mortality and a clinically-significant neurological                 
morbidity (1). In children and adolescents, bacterial intracerebral abscess is 
a particularly serious condition often leading to permanent neurological 
sequelae or death (6,17). Sequelae have been reported in 9-36 % of patients 
(6,63,65). To reduce the mortality and sequelae, rapid and accurate 
diagnosis and treatment are required. Close coordination between 
neurosurgeons, infectious diseases specialists, and microbiologists is 
increasingly important in the management of this disease (40). In most 
microbiology laboratories the diagnosis of brain abscess is based on culture 
from pus collected surgically (49,63). Culture usually takes 24 to 48 h to 
produce a result and is often inhibited by empirical antibiotic therapy. Also, 
standard culture methods are hampered in case of fastidious and 
noncultivable bacteria and thus might not be sufficient for a precise 
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microbiological evaluation of the infection. In the last decade, the 
widespread use of 16S rDNA PCR and sequencing has played a pivotal 
role in the accurate identification of bacterial isolates and the discovery of 
novel bacteria in clinical specimens (68). When applied to brain abscess 
specimens (32,47,64), 16S rDNA amplification and sequencing 
demonstrated a great advantage over culture to identify bacterial agents, 
notably for fastidious bacteria (1,32,47,64). More recently, multiple 
sequencing of 16S rDNA amplicons following cloning and multiple 
sequencing via high throughput pyrosequencing were used to analyze and 
evaluate the bacterial flora involved in brain abscess (1). These methods 
have demonstrated that the variety of brain abscess–associated bacterial 
species is much larger than previously reported and includes many 
anaerobes and uncultured bacteria from the oral cavity flora. In this review, 
we propose an overview of the various diagnostic methods used for brain 
abscess and discuss their advantages and pitfalls.  
 
1) Source of infection and etiologic microorganisms 
  Identifying the infectious source of a brain abscess is important for 
the appropriate management of the patient. Microorganisms can reach the 
brain by different mechanisms. Brain abscesses may develop when the 
integrity of the central nervous system is compromised (trauma or 
neurosurgery) in 8-19 % of cases (6), by direct extension from a contiguous 
suppurative focus (sinuses, middle ear, mastoids, oral cavity) in 25-50 % of 
cases (26,40,69), or by hematogenous dissemination from a distant focus in 
15-30 % of cases (26,69). Despite all these potential routes, 20% - 30% of 
cases, for which no obvious source can be identified, are classified as 
cryptic brain abscesses (40,69). Etiologic organisms vary according to the 
source of infection as well as the immunocompetence of the host (1,40). 
Polybacterial infections are frequent in case of brain abscesses 
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complicating a sinusitis or a dental abscess (1), and most frequently 
associate Streptococcus species, Bacteroides species, Prevotella species, 
Porphyromonas species, Fusobacterium species, and Micrococcus micros 
(1). Furthermore, many as yet uncultured bacteria were also found in this 
situation (1,36).  Brain abscesses from otogenic origin mostly associate 
Streptococcus species, Bacteroides species, Pseudomonas aeruginosa, and 
Enterobacteriaceae. In case of metastatic spread, the most commonly 
reported bacteria were Staphylococcus aureus, viridans streptococci 
(endocarditis), Enterobacteriaceae and Pseudomonaceae (urinary tract 
infections), Streptococcus species, Enterobacteriaceae and anaerobes 
(intra-abdominal infections), Streptococcus species, Fusobacterium species 
and Actinomyces species (lung abcess). In brain abscess resulting from a 
penetrating truma, Staphylococcus aureus, Clostridium species, and 
Enterobacteriaceae are the most common causative agents. Following 
neurosurgical procedures, the most common agents are Staphylococcus 
aureus, Staphylococcus epidermidis, Enterobacteriaceae, and 
Pseudomonaceae. Immunocompromised patients with HIV infections, 
organ transplantation, chemotherapy, or steroid use suffer infections caused 
by Nocardia species, Staphylococcus species, Streptococcus species, and 
Pseudomonas species (1,36).  
 Using culture, polymicrobial infections are reported to represent  
only 11 % - 18 % of brain abscesses (36,49,56). However, these              
infections represented 40 % of all brain abscess samples using molecular 
techniques (1), at least one anaerobic bacterium being isolated in every 
case of polybacterial brain abscess (1), Currently, more than 147 bacterial 
taxa have been reported to cause brain abscess, including 29 reported for 
the first time using a metagenomic approach (1-3). These include                    
129 known species from 50 genera and 18 as yet unclassified and 
uncultured bacteria (Table 3). Among the 50 genera involved in                    
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brain abscess, the most represented were the Streptococcus genus, with                  
14 different species, followed by the Nocardia, Staphylococcus, 
Clostridium, and Prevotella genera (8 species each), the Haemophilus, 
Citrobacter, and Neisseria genera (5 species), the Salmonella genus                   
(4 species), and the Fusobacterium, Enterococcus, Campylobacter, 
Enterobacter and Proteus genera (3 species). Each of the remaining genera 
were represented by one or two species (Table 3).   
 Overall, the most common bacterial species causing brain abscess in 
the literature was S. intermedius, detected in 35 % of brain abscess samples 
(1,36). In polybacterial brain abscesses, most bacteria implicated were 
members of the oral flora, notably Streptococcus sp., Fusobacterium sp., 
Prevotella sp., Porphyromonas sp., Micromonas micros, and Bacteroides 
fraglis (1). In contrast, the most common species identified in cases of 
monobacterial brain abscesses were Streptococcus sp., Staphylococcus sp., 
Nocardia sp., Haemophilus sp., Enterococcus sp., Klebsiella pneumoniae, 
Escherichia coli, and Propionibacterium acnes (1,36,49).  
 
2) Culture and identification of clinical isolates 
Culture remains widely used as first line tool for the diagnosis of 
infectious diseases despite significant limitations such as transport issues, 
indeterminate and presumptive quantification and identification, as well as 
subjectively demanding techniques (11,34). In brain abscess, culture is 
mostly performed from pus collected by neurosurgical drainage (36,70). 
However, pus from brain abscess has been reported to be sterile in 9-63 % 
of cases (6,36,49,56,65). A recent study evaluated comparatively the 
bacterial spectrum of brain abscess using both culture and molecular 
techniques (1). The results demonstrated that culture was unable to detect a 
substantial proportion of the bacterial population that is fastidious or 
nonculturable. In addition, culture may be impaired by one of the following 
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problems. Administration of an empirical antibiotic therapy prior to 
specimen collection may prevent bacterial growth. Furthermore, in 
polymicrobial infections, cultivation can actually yield misleading answers 
if the antibiotics administered have affected the involved bacteria 
unequally, permitting some to grow and not the others. In previous studies, 
molecular methods have detected a significantly larger number of species 
than did culture for patients who had received antibiotics prior to sample 
collection (1,30). The nutritional media used for sample transportation and 
the general conditions of transportation may also influence culture results. 
As a matter of fact, a given medium allows continued growth of species 
that are most satisfied with the transport medium during transport until the 
sample is finally plated for culture. This growth results in a significant 
change in the balance of microbes present since some species will more 
actively grow at the expense of others. Another factor is the atmosphere 
used to incubate the pus specimen. This is especially the case for anaerobic 
bacteria, as they require adequate transport conditions and special care in 
the laboratory, which are not systematically achieved (1). In many studies, 
anaerobic bacteria have only been detected by molecular methods 
(1,30,31). Most bacteria grow within 24 to 72 hours. However, some 
fastidious bacteria need more than 5 days to be cultivated (2). As an 
example, Nocardia sp. isolation and susceptibility testing may take weeks 
and, due to time-consuming phenotypic methods, nocardiosis is sometimes 
diagnosed after the dissemination of the strain to other organs or after the 
patient is death (27,37,54). In addition, in polymicrobial infections, 
fastidious bacteria such as Mycoplasma sp. may be overgrown in culture by 
other faster-growing organisms. It is also widely accepted that plate 
culturing techniques may  only reveal a small portion of the true microbial 
population, primarily due to an inability of detecting organisms that might 
not be cultivable with existing media, require specific temperature, phases 
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of metabolic activity, and the inability of recovering known 
microorganisms which are viable but enter a non-cultivable state 
(10,16,35).   
An additional problem related to culture methods is the isolation and 
identification of predominant bacteria and not the other species which are 
present in lower concentration. This may also be due to difficulties in 
differentiating colonies on agar plates. Contamination of the culture 
medium is one of the most frustrating problems that can be faced by 
laboratories and physicians (4,5). Poor plating techniques or use of an 
improper device for plating the collected samples can contaminate the 
culture medium by external bacteria or fungi. Such a contamination can 
result in a misleading diagnosis that has both financial and therapeutic 
implications (4,5,59). Such contaminations were reported in previous 
studies of brain abscess samples (1,3,32).  
Regarding identification, in most brain abscess studies, bacterial 
identification was obtained using manual or automated biochemical tests. 
However, conventional methods sometimes fall short when they exhibit 
unusual phenotypic profiles or express few of the phenotypic criteria 
characterized by these methods, as is the case for Mycoplasma species. In 
contrast, recent advances in DNA sequencing technology have greatly 
enhanced the ability of the microbiologist to identify precisely a bacterial 
isolate (28). In particular, 16S rRNA gene sequence determination and 
comparison to the GenBank database enabled the description of 
Staphylococcus massiliensis sp. nov. (3) for a Staphylococcus strain 
isolated from a brain abscess that could not be characterized using 
phenotypic methods (3). Therefore, culture may often underestimate the 
bacterial species present in brain abscess pus. 
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In contrast, to date, culture cannot be replaced by other methods for 
determining the complete antibiotic susceptibility profile of bacterial 
isolates.  
 
3) Molecular detection 
 
3-1. Direct 16S rDNA Gene Amplification and Sequencing  
 
In recent years, molecular methods have increasingly been used to 
detect microorganisms in clinical samples, including those from patients 
with central nervous system infections. Among genes that were used as 
PCR targets, rRNA-encoding genes, present in all bacterial genomes, 
contain highly conserved sequences (39). Most works were focused on the 
use of 16S rRNA, which enabled the identification of fastidious, 
uncultured, and novel microorganisms (40,41). Identifying bacteria isolated 
in the clinical laboratory by sequence instead of phenotype has improved 
clinical microbiology by better identifying poorly described, rarely 
isolated, or biochemically aberrant strains. 16S rRNA gene sequences 
allow a more robust, reproducible, and accurate bacterial identification than 
phenotypic testing (1-3,19,28), notably by comparison to the GenBank 
database (67). Many studies using 16S rRNA PCR and sequencing were 
undertaken to evaluate the usefulness of broad range bacterial PCR and 
sequencing in the aetiological diagnosis of clinically suspected intracranial 
or spinal infection (1-3,21,32,61). The results were in accordance with 
earlier reports of other infections (25,31,43,53), showing that broad range 
bacterial rDNA PCR may be the only method to yield an aetiological 
diagnosis in several situations including the administration of antibiotics 
prior to sampling or the presence of fastidious pathogens (1,32,47,64).            
16S rRNA gene amplification and sequencing demonstrated its usefulness 
in providing a definite aetiology of intracerebral abscesses with negative 
 23 
culture results, allowing for more targeted treatment (47). As an example, 
PCR detection of Nocardia or mycobacteria was accomplished in 1 to                 
2 days, compared with culture that could take weeks (8,38).  
However, 16S rDNA amplification and sequencing suffer from 
several drawbacks. These include, a limited discriminatory power among 
taxa in complex floras (containing more than one bacterial species). For 
these samples, direct sequencing results in mixed chromatograms 
(uninterpretable sequences) containing two or more fluorescent signals at 
nucleotide positions where the 16S rRNA genes differ between strains 
(1,29,30,32,64). The problem may be solved by separating PCR products 
by cloning or using gradient gel electrophoresis, but these methods are 
labor-intensive and not suitable for routine diagnostics (1,29,30). Another 
drawback of PCR is its limited sensitivity (20). The consequence of a low 
sensitivity is that a negative broad-range PCR can never exclude the 
presence of bacterial DNA in a sample. Also, some samples might have 
produced false negative results due to the presence of inhibitory substances 
in specimens.  
Another disadvantage of PCR in the clinical setting is the 
contamination risk, with false positive results caused by cross 
contamination of target DNA between samples, or contamination of 
reagents and specimens with PCR amplicons (32). In addition, broad range 
16S rDNA may not differentiate bacteria at the species level (3). 
 
3-2. Restriction fragment length polymorphism (RFLP) 
 
Restriction fragment length polymorphism (RFLP) analysis of 16S 
rDNA amplicons has been used successfully to identification bacterial 
species following PCR (22,50). Whoever, RFLP was used only in few 
brain abscess studies (46,57), and enabling the identification of Nocardia 
otitidiscaviarum (46), Tsukamurella tyrosinosolvens (57), and 
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Streptococcus constellatus (39). Although, RFLP is cheap and accessible to 
many laboratories, it lacks discriminatory power, databases to be compared 
to, reproductibility and inter-laboratory comparability.  
 
3-3. 16S rDNA gene Cloning and Sequencing  
 
In the past decade, polymerase chain reaction (PCR) amplification of 
the bacterial 16S ribosomal RNA (rRNA) gene, followed by cloning and 
sequencing of the inserts, has resulted in improved identification of the 
bacterial diversity from polymicrobial clinical and environmental samples 
(45). Such metagenomic studies of dental, vaginal and intestinal floras 
were performed by combination of broad range polymerase chain reaction 
(PCR) amplification and cloning of PCR amplicons prior to sequencing to 
evaluate their microbial diversity (9,12,13,15,24,41,42). When applied to 
brain abscess specimens (1), this approach dramatically increased the 
number of identified agents. Metagenomic analysis of the bacteria 
associated with brain abscess has shown that this flora was significantly 
more variable than that characterized by culture or PCR and sequencing 
without cloning (1). Similar results have been obtained in studies of 
endodontic infections, dentoalveolar abscesses, dental caries, periodontitis 
and pulmonary infections in cystic fibrosis patients (9,12,19,24,41,42).  In 
a previous study, of the oral flora it was estimated that approximately 50 % 
of the bacteria involved were uncultured (58) and belonged to the 
Bacteroidetes and Firmicutes phyla. High throughput analyses of the 
bacteria associated with brain abscess showed that this flora was even more 
variable than expected, including 27 bacterial species found in cerebral 
abscesses that had not been previously reported (1). This study also 
permitted the identification of two novel bacteria, the first being a novel 
Staphylococcus species (3) and the second being a novel anaerobic and as 
yet unnamed species in a new genus within the phylum Bacteroidetes (2). 
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The increase in the repertoire of brain abscess-causative organisms directly 
results from the molecular detection of fastidious, and as yet uncultured, 
microorganisms. In particular, 15 contemporarily uncultured bacteria that 
had previously been characterized in the anaerobic periodontal and 
intestinal flora were found in brain abscess. 
The results of 16S rDNA gene cloning and sequencing may be 
influenced by many factors, including genome size and 16S rDNA gene 
copy number (14), cell lysis (48), DNA extraction and purification 
(33,44,62), choice of primers (18,51), PCR amplicon size (23), PCR 
conditions (55,60), and cloning conditions (51). In addition, it is unlikely 
that broad range primers will amplify all bacteria. Some cultured bacteria 
were not found by sequencing. These are examples of one of the limitations 
attached to sequencing from mixed clinical samples. Because DNAs from 
all bacteria in a sample compete for the same reagents, those present at the 
lowest concentrations might be under-amplified in the PCR and not visible 
in the resulting DNA chromatogram (29,30). Also, amplification of DNA 
from mixed bacterial templates may result in the formation of chimeric 
molecules that do not truly represent any valid organism (66). The presence 
of such molecules can compromise the integrity of sequence databases and 
cause misinterpretation of the phylogenetic status by the creation of false 
genetic diversity within prokaryotes. The percentage of chimeric inserts in 
16S rDNA gene libraries generated from brain abscesses samples were 
reported to range from 0 to 5 %, depending of the sample, and such 
sequences should be excluded from analyses (1). The presence of chimeric 
sequences in 16S rDNA libraries may be verified using the CHIMERA_ 
CHECK program of the Ribosomal Database Project II (7).  However, 
some microorganisms may possess naturally-occurring mosaic-like 16S 
rRNA genes that may be misidentified as experimental chimeras when 
complex DNA is used as a template, eventually affecting the overall 
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estimation of community structure (52). Another important factor is the 
number of clones which are necessary to represent the bacterial population 
present in the sample. Nevertheless by enabling the detection of many new 
agents of brain abscess, cloning and sequencing of 16S rDNA PCR 
products is a highly valuable approach to characterize the diversity of the 
brain abscess flora. Previous results suggested that 100 clones might not be 
enough to enable identification of all the bacterial species present in a 
polymicrobial sample (1).  
 
Conclusion  
Brain abscess is a life-threatening infection with frequent serious 
sequelae, whose medical management remains empirical due to a lack of 
comprehensive knowledge of the causative microorganisms. To reduce the 
mortality and sequelae, rapid and accurate diagnosis and treatment are 
required. Identifying the immunocompetence of the host and the possible 
source of infection is so important and can give an idea about the spectrum 
of the bacteria implicated. Microbiological documentation of brain abscess 
primarily relies on direct microscopic examination and culturing of abscess 
pus collected after neurosurgical drainage. Unfortunately, this procedure 
has many limitations and reveals only a small portion of the true microbial 
population. In addition, Conventional methods for the identification and 
characterization of clinical isolates of bacterial pathogens sometimes fall 
short when such isolates exhibit unusual phenotypic profiles. PCR and 
sequencing technology offer a more rapid and accurate identification than 
that obtained with standard culture methods. PCR-amplified 16S rDNA 
sequencing can be used to overcome the limitations of culture-based 
bacteria detection in brain abscess pus. Unfortunately, this procedure fails 
to discriminate among mixed flora. Thus, amplification of the bacterial   
16S rRNA gene followed by cloning and sequencing represent the best 
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methods to resolve the limitations related to culture and direct 16S rRNA 
gene amplification and sequencing. Also, the combination of all these 
procedures may be indispensable to better understand the situation. 
Therefore, 16S rRNA gene cloning and sequencing is time consuming and 
labor intense. So, a more rapid and accurate procedure may be necessary in 
the future to overcome all limitations and to improve the diagnosis of brain 
abscess.  
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Table 1: 147 bacterial taxa detected from brain abscess to date.  These belong to 
129 species from 50 genera, and 18 as yet uncultured bacteria. 
 
    
1 Streptococcus intermedius  74 Enterobacter cloacae 
2 Streptococcus constellatus  75 Enterobacter sakazakii  
3 Streptococcus pneumoniae   76 Enterobacter aerogenes   
4 Streptococcus anginosus  77 Enterococcus faecalis 
5 Streptococcus sanguis 78 Enterococcus faecium 
6 Streptococcus salivarius 79 Enterococcus avium  3  
7 Streptococcus equi  80 Campylobacter rectus 
8 Streptococcus equinus 81 Campylobacter gracilis  
9 Streptococcus mutans 82 Campylobacter fetus  3 
10 Streptococcus oralis 83 Porphyromonas endodontalis  
11 Streptococcus milleri 84 Porphyromonas gingivalis  
12 Streptococcus bovis  85 Mycoplasma hominis    
13 Streptococcus acidominimus 86 Mycoplasma faucium     
14 Streptococcus pyogenes   87 Klebsiella pneumoniae  
15 Clostridium butyricum 88 Klebsiella oxytoca   
16 Clostridium sordellii  89 Burkholderia pseudomallei 
17 Clostridium tertium 90 Burkholderia cepacia   
18 Clostridium perfringens 91 Capnocytophaga canimorsus 
19 Clostridium septicum  92 Capnocytophaga ochracea   
20 Clostridium glycolicum 93 Brucella abortus  
21 Clostridium ramosum 94 Brucella melitensis  
22 Clostridium bifermentans 95 Eubacterium lentum 
23 Clostridium difficile 96 Eubacterium brachy   
24 Clostridium clostridioforme   97 Micrococcus varians 
25 Nocardia farcinica 98 Micrococcus luteus   
26 Nocardia asteroides  99 Peptostreptococcus anaerobius 
27 Nocardia otitidiscaviarum 100 Peptostreptococcus stomatis   
28 Nocardia cyriacigeorgia 101 Gemella haemolysans 
29 Nocardia nova 102 Gemella morbillorum   
30 Nocardia abscessus 103 Abiotrophia adiacens 
31 Nocardia cavia 104 Abiotrophia defectiva  
32 Nocardia transvalensis    105 Escherichia coli  
33  Staphylococcus capitis 106 Propionibacterium acnes 
34 Staphylococcus epidermidis 107 Micromonas micros  
35 Staphylococcus aureus 108 Bacteroides fragilis 
36 Staphylococcus xylosus 109 Mogibacterium timidum   
37 Staphylococcus massiliensis  110 Treponema maltophilum   
38 Staphylococcus simulans 111 Mycobacterium tubercolosis 
39 Staphylococcus haemolyticus 112 Listeria monocytogenes 
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40 Staphylococcus lugdunensi   113 Dialister pneumosintes 
41 Prevotella oris  114 Eikenella corrodens 
42 Prevotella intermedia  115 Serratia marcescens  
43 Prevotella tannerae   116 Bilophila wadsworthia 
44 Prevotella baroniae   117 Acinetobacter calcoaceticus  
45 Prevotella loescheii 118 Leuconostoc mesenteroides 
46 Prevotella melaninogenica 119 Rhodococcus equi  
47 Prevotella buccae 120 Lactobacillus fermentans 
48 Prevotella bivia   121 Morganella morganii 
49 Haemophilus aphrophilus  122 Kocuria varians 
50  Haemophilus parainfluenzae  123 Vibrio cholerae 
51 Haemophilus inflenzae  124 Tsukamurella tyrosinosolvens 
52 Haemophilus paraaphrophilus  125 Providencia rettgeri 
53 Haemophilus parahaemolyticus   126 Aggregatibacter actinomycetemcomitans 
54 Citrobacter koseri 127 Gordona terrae 
55 Citrobacter diversus 128 Phocaeicola abscesses  
56 Citrobacter sedlaki 129 Tsukamurella tyrosinosolvens 
57 Citrobacter freundi 130 Uncultured bacterium 1   
58 Citrobacter meningitis   131 Uncultured bacterium 2   
59 Neisseria sicca 132 Uncultured bacterium 3   
60 Neisseria mucosa 133 Uncultured bacterium 4   
61 Neisseria meningitidis 134 Uncultured bacterium 5  
62 Neisseria sicca 135 Uncultured bacterium 6  
63 Neisseria elongata  136 Uncultured bacterium 7  
64 Salmonella typhimurium 137 Uncultured bacterium 8  
65 Salmonella enteritidis 138 Uncultured bacterium 9  
66 Salmonella typhi  139 Uncultured Eubacterium E1-K13  
67 Salmonella entirica   140 Uncultured Eubacterium E1-K9  
68 Fusobacterium nucleatum  141 Uncultured Eubacterium sp.  
69 Fusobacterium necrophorum 142 Bacteroidales genomosp. oral clone  
70 Fusobacterium naviforme   143 Uncultured Prevotella sp.  
71 Proteus vulgaris 144 Prevotella sp. oral clone DO033  
72 Proteus rettgeri 145 Prevotella sp.  
73 Proteus mirabilis   146 Neisseria sp.   
  147 Capnocytophaga sp.   
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Figure 1:  Evolution of known bacterial species number (implicated in 
brain abscess) over the years. 
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OUTLINE OF THE THESIS 
In this thesis we focused our interest on the identification of the 
bacterial species associated with brain abscess. The purpose of the first 
study was to analyze and evaluate the bacterial flora responsible for brain 
abscess by comparing standard culture technique to three techniques using 
16S rDNA amplification, that is, direct sequencing, multiple sequencing 
following cloning, and multiple sequencing via high throughput 
pyrosequencing. We found that the molecular techniques dramatically 
increased the number of identified agents of cerebral abscess (Al Masalma 
et al. CID).  
This preliminary study identified 49 distinct brain abscess bacterial 
agents, and enabled the identification of 27 bacteria never detected before 
in brain abscess, 15 of which were uncultured. Such a high number of 
bacterial species involved in brain abscess prompted the study of 51 new 
specimens in an effort to describe further the flora associated with brain 
abscesses and their etiologies (Al Masalma et al submitted to JAMA). In 
concordance with the first study, this study showed that, the cloning and 
sequencing of PCR-amplified 16S rDNA is a highly valuable method to 
identify bacterial agents of brain abscesses. In addition, the combination of 
data from 71 patients (20 from the first series and 51 from the second 
series) enabled the identification of several associations using the data 
mining analysis.  
Also, these studies over permitted the identification of two novel 
bacteria, the first being a novel Staphylococcus species, Staphylococcus 
massiliensis (Al Masalma et al. IJSEM), and the second being a novel 
anaerobic bacterium that represents a novel species in a new genus within 
the phylum Bacteroidetes, Phocaeicola abscesse (Al Masalma et al. 
IJSEM ). 
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We also described a case of M. hominis brain abscess in a female 
patient following uterus curettage. The diagnosis was obtained by 16S 
rDNA amplification, cloning and sequencing from the abscess pus, and 
confirmed by a specifically-designed real-time PCR assay. To facilitate the 
detection of this agent, we developed an accurate, sensitive, and specific 
RT-PCR assay for M. hominis, that may enable the diagnosis to be obtained 
within one hour after DNA extraction (Al Masalma et al. Transplantation 
Proceedings).  
We report also, an unusual case of Nocardia carnea brain and lung 
abscesses in a kidney transplant recipient. Our case was confirmed by 
molecular detection despite negative cultures (Al Masalma et al. 
submitted to JMCR).  
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Preamble 
Brain abscess is a life-threatening infection with frequent serious 
sequelae [4, 6, 9-12]. Currently, the detection of bacterial pathogens in 
brain abscesses is mostly obtained using culture from pus collected by 
neurosurgical drainage. However, pus culture remains sterile in 9-63 % of 
cases. Over the past decade, 16S rDNA amplification and sequencing was 
successfully used to detect bacteria in brain abscess specimens [16-18, 27]. 
However, this method was impaired in cases of polymicrobial infection. 
Recently, studies of dental, vaginal and intestinal flora were performed by 
combination of broad range polymerase chain reaction (PCR) amplification 
with cloning of PCR amplicons to evaluate their microbial diversity [20, 
21, 24-26, 28-30]. These approaches were proved useful to evaluate the 
bacterial diversity.  
In this study we applied this technique to 20 brain abscess samples to 
evaluate the spectrum of bacteria implicated in this condition. The purpose 
was to analyze and evaluate the bacterial flora responsible for brain abscess 
by comparing standard culture technique to three techniques using 16S 
rDNA amplification, that is, (i) direct sequencing (providing a single 
sequence), (ii) multiple sequencing following cloning (providing around 
100 different sequences), and (iii) multiple sequencing via high throughput 
pyrosequencing using the 454 Life Science-Roche platform. 
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Bacteria were microscopically observed in 45 % of patients, while 
culturing on axenic media yielded bacteria in 80% of patients. The obtained 
cultures identified significantly fewer bacteria (22 strains) compared to 
molecular testing (72 strains). We found that a patient can exhibit as many 
as 16 different bacterial species in a single abscess. The obtained cultures 
identified 14 different species already known to cause cerebral abscess. 
Single sequencing performed poorly, while multiple sequencing identified 
49 species, of which 27 have not been previously reported in brain abscess 
investigations, and 15 are completely unknown. Interestingly, we observed 
two patients with Mycoplasma hominis (an emerging pathogen in this 
situation) and three patients with Mycoplasma faucium, which has never 
been reported in literature. 22 bacterial species were recovered by culture, 
whereas single sequencing identified only 15 bacteria and 5 mixed 
populations out of 19 positive amplicons. In contrast to single sequencing, 
multiple sequencing dramatically increased the number of identified 
bacteria.  
Our investigation has determined that the variety of brain abscess-
associated bacterial species is much larger than previously reported, and it 
includes many anaerobes and uncultured bacteria from oral cavity flora. 
The observed increase in the repertoire of brain abscess-causative 
organisms can be linked to molecular evidence for fastidious, and yet 
uncultured organisms. 
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M A J O R A R T I C L E
The Expansion of the Microbiological Spectrum
of Brain Abscesses with Use of Multiple 16S
Ribosomal DNA Sequencing
Mouhamad Al Masalma,1 Fabrice Armougom,1 W. Michael Scheld,4 Henri Dufour,2 Pierre-Hugues Roche,3
Michel Drancourt,1 and Didier Raoult1
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Background. Brain abscess is commonly treated using empirically prescribed antibiotics. Thus, a comprehensive
study of bacterial organisms associated with brain abscess is essential to define the best empirical treatment for
this life-threatening condition.
Methods. We prospectively compared cultures to single and multiple sequenced 16S ribosomal DNA polymerase
chain reaction amplifications (by cloning and/or pyrosequencing) of cerebral abscesses in 20 patients from 2
hospitals in Marseilles, France, during the period January 2005 through December 2007.
Results. The obtained cultures identified significantly fewer types of bacteria (22 strains) than did molecular
testing (72 strains; , by analysis of variance test). We found that a patient could exhibit as many as 16Pp .017
different bacterial species in a single abscess. The obtained cultures identified 14 different species already known
to cause cerebral abscess. Single sequencing performed poorly, whereas multiple sequencing identified 49 species,
of which 27 had not been previously reported in brain abscess investigations and 15 were completely unknown.
Interestingly, we observed 2 patients who harbored Mycoplasma hominis (an emerging pathogen in this situation)
and 3 patients who harbored Mycoplasma faucium, which, to our knowledge, has never been reported in literature.
Conclusions. Molecular techniques dramatically increased the number of identified agents in cerebral abscesses.
Mycoplasma species are common and should be detected in this situation. These findings led us to question the
accuracy of the current empirical treatment of brain abscess.
Brain abscess is a life-threatening condition [1–4] with
frequent serious sequelae [3, 5, 6] for which medical
management remains empirical because of a lack of
comprehensive knowledge regarding the organisms re-
sponsible. Microbiological documentation of brain ab-
scess primarily relies on direct microscopic examination
and culturing of abscess pus specimens collected after
neurosurgical drainage [4, 7]. Unfortunately, this pro-
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March 2009.
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cedure produces inconclusive results in 9%–63% of
cases, depending on the quality of anaerobe culturing
[6].
PCR-amplified 16S ribosomal DNA (rDNA) se-
quencing was recently used to overcome the limitations
of culture-based bacteria detection in brain abscess pus
specimens, and it was demonstrated to be effective for
documentation of monomicrobial infection after an-
tibiotic treatment. Unfortunately, this procedure failed
to discriminate among mixed flora [8–11]. As such, we
suspect that the number of species associated with brain
abscess is much larger than previously expected.
The purpose of this investigation was to analyze and
evaluate the bacterial flora responsible for brain abscess
by comparing standard culture technique to the fol-
lowing 3 techniques using 16S rDNA amplification: (1)
direct sequencing (providing a single sequence), (2)
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Table 1. Sequences of primers used for PCR and sequencing.
Procedure, primer
or probe name Sequence
16S rDNA amplification
fD1 5′-AGA GTT TGA TCC TGG CTC AG-3′
rp2 5′-ACG GCT ACC TTG TTA CGA CTT-3′
Insert amplification
M13d 5′-CAG GAA ACA GCT ATG AC-3′
M13r 5′-GTA AAA CGA CGG CCA G-3′
Sequencing
536r 5′-GTA TTA CCG CCG CTG CTG-3′
536f 5′-CAG CAG CCG CCG TAA TAC-3′
800f 5′-TAG ATA TAC CCG GTT AG-3′
800r 5′-CTA CCA GGG TAT CTA AT-3′
1050r 5′-CAC GAG CTG ACG ACA-3′
1050f 5′-TGT CGT CAG CTC GTG-3′
multiple sequencing following cloning (providing ∼100 differ-
ent sequences), and (3) multiple sequencing via high-through-
put pyrosequencing with use of the 454 Life Sciences–Roche
platform. These approaches have been previously used to ex-
plore mixed dental, vaginal, pulmonary, and intestinal flora
[12–18]. The 20 case studies presented here indicate a tremen-
dously expanded spectrum of bacterial species associated with
brain abscess, including 27 species never before described in
relation to this condition.
MATERIALS AND METHODS
Patients and clinical specimens. This study includes 20 pa-
tients who underwent surgical drainage of brain abscess in
Marseille, France, hospitals during the period January 2005
through December 2007. Brain abscess was defined as a local-
ized suppurative focus that was visible by CT or MRI and for
which histological analysis confirmed the presence of pus and
excluded the presence of cancerous and lymphomatous cells.
Demographic data were anonymously collected for each patient
and included age, sex, potential source of contamination, and
underlying predisposing factors (table 1). The study was ap-
proved by the local ethics committee. Pus specimens were col-
lected in operating rooms equipped with laminar flow systems
and high-efficiency particulate air filters, using sterile devices
with aseptic, surgical procedures in sterile tubes and immedi-
ately sent to the bacteriology laboratory for culture and mo-
lecular investigations.
Microbiological methods. Pus specimens were microscop-
ically examined after Gram staining to note the presence of
polymorphonuclear leukocytes and bacteria. They were then
plated on blood agar and chocolate agar plates (bioMe´rieux)
and incubated at 37C under 5% CO2 and in anaerobic con-
ditions. The plates were examined daily for the presence of
colonies over the course of 10 days. Pure bacterial cultures were
obtained from isolated colonies and identified using the Vitek
2 instrument and API identification strips (bioMe´rieux). Cell
culturing of human embryonic lung and endothelial cells was
performed with use of the shell-vial centrifugation technique
[19] for specimens preserved at20C in case the axenic media
remained sterile. The isolates were molecularly identified via
16S rDNA sequencing [20].
Direct detection of organisms by PCR in brain abscesses.
Molecular detection was performed by 16S rDNA amplification
and sequencing using 3 levels of depth (figure 1). Amplicons
can be directly sequenced (single sequencing). In some samples,
this was troublesome, because sequences demonstrated evi-
dence of mixed infection (figure 1). To detect mixed infection,
we analyzed multiple sequences using 2 methods. We first tested
125 different sequences after cloning into Escherichia coli. We
later used high-throughput pyrosequencing on the amplicons,
which permitted us to obtain 250,198 kb of sequence—that is,
2612 different sequences in 1 test. A 98.5% 16S rDNA sequence
similarity was used to delineate species [21]. The 16S rDNA
sequences representing novel phylotypes were deposited in
GenBank (table 2).
Direct 16S rDNA PCR amplification and sequencing.
After proteinase K treatment and mechanical lysis using the
FastPrep FP120 instrument (BIO101 Systems), complete DNA
was extracted from pus specimens using the MagNA Pure LC
DNA isolation kit II and the MagNA Pure LC instrument
(Roche). Negative controls, which included sterile water instead
of DNA, were run in parallel. After decontamination of the
PCR mix by incubation with AluI [22], 16S rDNA PCR am-
plification and sequencing were performed as described else-
where [20]. Purified sequencing products were analyzed on an
ABI PRISM 3130X Genetic Analyzer (Applied Biosystems). Se-
quences assembled using SEQUENCHER software (Applied
Biosystems) were compared with those deposited in the Na-
tional Center for Biotechnology Information GenBank database
using the BLAST program (http://www.ncbi.nlm.nih.gov). The
b-globin gene was amplified in parallel using the primer pair
KM29 (5′-GGT TGG CCA ATC TAC TCC CAG G-3′) and RS42
(5′-GCT CAC TCA GTG TGG CAA AG-3′) to ensure DNA
extraction efficiency and the absence of PCR inhibitors (ta-
ble 1).
Cloning PCR-amplified 16S rDNA. The PCR-amplified
16S DNA was cloned using the pGEM-T Easy Vector System
with JM109 competent E. coli (Promega) in accordance with
the manufacturer’s instructions. For each pus specimen, 125
white colonies were analyzed by PCR amplification using the
universal primers M13d and M13r. Chimeric sequences found
in the libraries using the CHIMERA_ CHECK program of the
Ribosomal Database Project II [23, 24] were excluded from the
analysis.
16S rDNA high-throughput pyrosequencing. The 16S
New Bacteria in Brain Abscesses • CID 2009:48 (1 May) • 1171
Figure 1. 16S ribosomal DNA (rDNA) sequence-based molecular investigation of brain abscess flora using direct and multiple sequencing. FLEX
was manufactured by Life Science–Roche.
rDNA amplified from the specimen of one patient was purified
and sequenced using the GS FLX platform (454 Life Sciences-
Roche) on a PicoTiterPlate (PTP) with 8 regions40 75
(Roche) [25]. Reads exhibiting a sequence similarity 98.5%
and a 90% sequence coverage with any hit in the Ribosomal
Database Project II (http://rdp.cme.msu.edu/) using the BLAST
algorithm were identified at the species level; reads exhibiting
97%–98.5% sequence similarity and a sequence coverage90%
were identified at the genus level; and reads exhibiting a se-
quence similarity !97% were not classified. The number of
reads assigned to a given species or genus was calculated. Only
species and genera that collected 110 reads were kept for primer
design and PCR amplification control. The Nucmer function
from the MUMmer 3.20 package [26] was used to map the
reads classified in a species onto the reference 16S rDNA. De-
fault parameters were used.
Literature search strategy and selection criteria. The
PubMed database was searched for articles published during
the period 1980 through April 2008 with the combined search
term “brain AND abscess.” Additional articles were identified
by hand-searching the bibliographies of selected papers. The
strategy was developed by splitting the review into its elemental
facets. Additional search terms included “microbiology,” “bac-
teriology,” “16S,” “molecular,” “detection,” “metagenomics,”
“Mycoplasma hominis,” “Mycoplasma faucium,” and “Myco-
plasma orale.” The publication language was restricted to En-
glish. The bibliographies of key references were later hand-
searched to identify articles missing in the database search.
RESULTS
Patients. Twenty patients were prospectively included in this
study (table 2), including 15 male patients (75%) and 5 female
patients (25%). The mean age of patients was 54.5 years (range,
14–76 years), and there were 2 children aged !15 years. Head-
ache was the most common clinical manifestation and was
observed in 10 patients; fever and motor weakness were ob-
served in 7 patients; vomiting and/or nausea, alterations in
consciousness, and aphasia were observed in 6 patients; visual
problems were observed in 4 patients; weight loss was observed
in 3 patients; other neurological manifestations were observed
in 3 patients; convulsions were observed in 2 patients; and
vertigo was observed in 2 patients. CT and MRI detected a
single brain abscess in 15 patients (75%) and multiple brain
abscesses in 5 patients (25%). A solitary abscess was localized
to the parietal lobe in 5 patients, to the frontal lobe in 4 patients,
to the occipital lobe in 2 patients, to the temporal lobe in 2
patients, to a frontoparietal location in 1 patient, and to a
parieto-occipital location in 1 patient. Brain abscess after neu-
rosurgery occurred in 4 patients (25%), whereas contiguous
infection after sinusitis or dental abscess was the second most
frequent source of brain abscess in 7 patients (35%). Aggre-
gatibacter aphrophilus pneumonia was a possible source of he-
matogenous spread in 1 patient, whereas no primary source
could be identified in 8 patients (40%). Underlying conditions
were noted for 9 patients. Direct microscopic examination of
pus revealed bacteria in 9 patients, whereas cultures yielded 1
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Figure 2. Gram-stained brain abscess pus (A) for 1 patient indicating gram-positive cocci when high-throughput pyrosequencing demonstrated 13
different bacterial species delineated in a phylogenetic tree (bootstrap values 90% are indicated at nodes; B).
bacterial species in 12 patients (60%), yielded 2 bacterial species
in 5 patients (25%), and were sterile in 3 patients (15%). The
negative controls remained negative in all PCR experiments.
Discrepancy between culture and molecular detection.
Direct 16S rDNA PCR amplification results were negative for
1 specimen and positive for 19 of 20 specimens, including 5
instances in which mixed flora were detected because of trou-
bled sequences. Altogether, direct 16S rDNA sequencing per-
formed marginally worse than cultures ( , by analysisPp .048
of variance). Among the 14 interpretable sequences, Strepto-
coccus intermedius was detected in 5 patients. Further identi-
fications included Acinetobacter calcoaceticus, M. hominis, Bac-
teroides fragilis, Serratia marcescens, Streptococcus pneumoniae,
Nocardia cyriacigeorgia, Neisseria species, A. aphrophilus, and
Staphylococcus aureus (1 patient each). In 9 specimens, the same
bacterial species were detected by culture and direct 16S rDNA
sequencing. One specimen that yielded negative results by 16S
rDNA PCR detection (the b-globin positive control yielded
positive results) exhibited the presence of Nocardia species by
cell culture. Three specimens that had negative culture results
yielded 1 bacterial species by direct 16S rDNA PCR. In 1 case,
culture yielded Klebsiella oxytoca, whereas direct 16S rDNA
sequencing yielded B. fragilis. For 4 specimens, cultures yielded
Streptococcus species mixed with another bacterial species,
which agreed with direct 16S rDNA sequencing that indicated
mixed flora. For 1 specimen, culture yielded S. intermedius and
Staphylococcus epidermidis, whereas direct 16S rDNA sequenc-
ing identified only S. intermedius. For 1 specimen, culture
yielded Streptococcus species, whereas direct 16S rDNA se-
quencing exhibited mixed flora.
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Multiple sequencing of amplicons. A total of 2100 non-
chimeric inserts of ∼1500 bp were sequenced, corresponding
to 1100 clones for each pus specimen. In 11 specimens, only
1 bacterial species was detected that was identical to that de-
tected by direct 16S rDNA sequencing. In 8 patients, clone
library analysis identified bacteria that had not been found
using direct 16S rDNA sequencing (table 2). A total of 2612
reads, with a mean length of 95.78 bp, were obtained after the
pyrosequencing of patient 10. In this patient, 2 bacterial species
were found by culture, 10 were found by multiple sequencing
after cloning, and 16 were found by high-throughput multi-
ple sequencing (figure 2). Altogether, 72 bacterial strains were
identified, compared with the 22 species identified by cul-
ture ( , by analysis of variance test); 8 mixed infectionsPp .017
were identified, compared with 5 identified by culture (Pp
).nonsignificant
DISCUSSION
The current knowledge base of bacteria that cause brain ab-
scesses relies on cultures of pus specimens collected after neu-
rosurgical drainage [1, 27, 28]. In this study, bacteria were
microscopically observed in 45% of patients, whereas culturing
on axenic media yielded bacteria in 80% of patients. No isolate
was obtained from patients who received antibiotics at the time
of pus collection (patients 1 and 17), as has been reported
elsewhere [2, 11, 27]. One Nocardia strain was isolated with
use of only a cell culture system. The spectrum of bacteria
isolated from brain abscess pus highly depends on the atmo-
sphere and culture media used to inoculate the specimen. In
particular, the prevalence of anaerobic bacteria is highly vari-
able, because these bacteria require adequate transport con-
ditions and special care in the laboratory, which were not sys-
tematically achieved in our study. In fact, no anaerobic
bacterium was cultivated in this study, in contrast with the
reported prevalence of anaerobes reported in other studies [29].
This fact limits the value of our comparison between culture
and molecular diagnostic tools. Molecular detection pointed to
mixed flora, including anaerobes, in patients with underlying
dental or sinus infection.
In this study, pus was collected into a sterile tube using sterile
devices and surgical procedures, virtually eliminating the risk
of perioperative contamination of the pus specimen. Absence
of intralaboratory contamination was interpreted by the neg-
ativity of negative controls and the general concordance of
various methods. S. epidermidis, which was isolated from 2
patients, was interpreted as a contaminant during processing
of the specimen. Indeed, S. epidermidis organisms were found
by culture only and were not detected by direct or multiple
16S rDNA gene sequencing. In both cases, other organisms,
including S. intermedius, were consistently found by culture
and molecular detection. Except for S. epidermidis, all organ-
isms herein reported were regarded as authentic—that is, in-
deed present in the pus specimen. The cloning method we used
provided a semiquantitative evaluation of the relative abun-
dance of each bacterial species, which all represented 11% of
the actual bacterial flora.
Direct 16S rDNA PCR amplification and sequencing have
seldom been used to circumvent the pitfalls associated with
culture-based techniques. Three studies have demonstrated that
the results obtained by direct PCR amplification and sequencing
for bacterial identification were more sensitive and precise than
was phenotypic identification [8, 10, 11]. In particular, the
detection of fastidious organisms, such as M. hominis, Gemella
morbillorum, A. aphrophilus, and Fusobacterium necrophorum,
was more rapid with molecular detection than with culture [8,
10]. In addition, molecular detection identified streptococci in
children who received antibiotics prior to brain abscess punc-
ture [11]. Unfortunately, single 16S rDNA PCR sequencing is
inadequate for clinical specimens that contain mixed flora; this
approach yielded mixed, uninterpretable sequences, as was pre-
viously described for brain abscess specimens [8, 10]. Therefore,
we used 2 complementary approaches to resolve this issue and
to allow for multiple sequencing: 16S rDNA clone library anal-
ysis and high-throughput pyrosequencing (in 2 cases). This
strategy yielded excellent results, whereas cultures recovered 22
bacteria species and single sequencing identified only 15 bac-
teria species and 5 mixed populations from 19 positive am-
plicons. This strategy also facilitated the identification of 1 par-
ticularly fastidious bacterium not usually observed by culturing
(i.e., M. hominis).
In contrast to single sequencing, multiple sequencing dra-
matically increased the number of identified bacteria (72 bac-
teria species, compared with 22 for culture [ ] and 14Pp .017
for single sequencing [ ]). The power of multiple se-Pp .048
quencing was demonstrated in patient 10, for whom cultures
yielded 2 bacterial species and high-throughput sequencing re-
covered 16 species. Three species were found by culture alone,
including 1 Nocardia species (obtained only by cell culture) and
2 S. epidermidis isolates. We suspect that the latter 2 cases
resulted from contamination during the inoculation procedure.
Multiple sequencing also identified 3 patients with mixed in-
fections that were not detected by direct sequencing or culture.
We detected anaerobes using only 16S rDNA amplification
in 40% of specimens. This potentially represents a flaw in our
laboratory, because others have recovered comparatively more
anaerobes by culture. Further developments in molecular bi-
ology may, in the future, help avoid this problem of fastidious
anaerobe isolation. We detected the presence of Mycoplasma
species in 25% of the specimens; in 4 of 5 cases, the Mycoplasma
species were part of mixed flora abscesses and were not detected
by direct sequencing. M. hominis should be regarded as an
emerging pathogen in brain abscesses; we detected this species
Table 3. The bacterial species detected in different patients by culture, 16S ribosomal DNA (rDNA) direct sequencing,
and/or 16S rDNA multiple sequencing.
Species (GenBank accession number) Means of identification
Species commonly reported in brain abscesses
Streptococcus intermedius Culture, 16S rDNA direct sequencing, and 16S rDNA multiple sequencing
Streptococcus constellatus Culture, 16S rDNA direct sequencing, and 16S rDNA multiple sequencing
Streptococcus pneumoniae Culture, 16S rDNA direct sequencing, and 16S rDNA multiple sequencing
Streptococcus anginosus Culture, 16S rDNA direct sequencing, and 16S rDNA multiple sequencing
Staphylococcus aureus Culture, 16S rDNA direct sequencing, and 16S rDNA multiple sequencing
Gemella haemolysans Culture, 16S rDNA direct sequencing, and 16S rDNA multiple sequencing
Gemella morbillorum 16S rDNA multiple sequencing
Escherichia coli Culture, 16S rDNA direct sequencing, and 16S rDNA multiple sequencing
Acinetobacter calcoaceticus 16S rDNA direct sequencing and 16S rDNA multiple sequencing
Eikenella corrodens Culture, 16S rDNA direct sequencing, and 16S rDNA multiple sequencing
Klebsiella oxytoca Culture, 16S rDNA direct sequencing, and 16S rDNA multiple sequencing
Serratia marcescens Culture, 16S rDNA direct sequencing, and 16S rDNA multiple sequencing
Aggregatibacter aphrophilus 16S rDNA direct sequencing and 16S rDNA multiple sequencing
Micromonas micros 16S rDNA multiple sequencing
Fusobacterium nucleatum 16S rDNA multiple sequencing
Porphyromonas endodontalis 16S rDNA multiple sequencing
Porphyromonas gingivalis 16S rDNA multiple sequencing
Prevotella oris 16S rDNA multiple sequencing
Prevotella intermedia 16S rDNA multiple sequencing
Bacteroides fragilis 16S rDNA direct sequencing and 16S rDNA multiple sequencing
Species rarely reported in brain abscesses
Nocardia cyriacigeorgia Culture, 16S rDNA direct sequencing, and 16S rDNA multiple sequencing
Nocardia species Culture
Mycoplasma hominis 16S rDNA direct sequencing and 16S rDNA multiple sequencing
Fusobacterium naviforme 16S rDNA multiple sequencing
Staphylococcus epidermidis Culture
Species never previously reported in brain
abscesses
Mycoplasma faucium 16S rDNA multiple sequencing
Campylobacter gracilis 16S rDNA multiple sequencing
Peptostreptococcus stomatis 16S rDNA multiple sequencing
Eubacterium brachy 16S rDNA multiple sequencing
Mogibacterium timidum 16S rDNA multiple sequencing
Prevotella tannerae 16S rDNA multiple sequencing
Prevotella baroniae 16S rDNA multiple sequencing
Prevotella species (EU663611) 16S rDNA multiple sequencing
Neisseria species (EU663609) 16S rDNA multiple sequencing
Capnocytophaga species (EU663610) 16S rDNA multiple sequencing
Campylobacter rectus 16S rDNA multiple sequencing
Treponema maltophilum 16S rDNA multiple sequencing
Uncultured bacterium 1 (EU663600) 16S rDNA multiple sequencing
Uncultured bacterium 2 (EU663601) 16S rDNA multiple sequencing
Uncultured bacterium 3 (EU663602) 16S rDNA multiple sequencing
Uncultured bacterium 4 (EU663603) 16S rDNA multiple sequencing
Uncultured bacterium 5 (EU663604) 16S rDNA multiple sequencing
Uncultured bacterium 6 (EU663605) 16S rDNA multiple sequencing
Uncultured bacterium 7 (EU663606) 16S rDNA multiple sequencing
Uncultured bacterium 8 (EU663607) 16S rDNA multiple sequencing
Uncultured bacterium 9 (EU66308) 16S rDNA multiple sequencing
Uncultured Eubacterium E1-K13 16S rDNA multiple sequencing
Uncultured Eubacterium E1-K9 16S rDNA multiple sequencing
Uncultured Eubacterium species 16S rDNA multiple sequencing
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Table 3. (Continued.)
Species (GenBank accession number) Means of identification
Bacteroidales genomosp. oral clone 16S rDNA multiple sequencing
Uncultured Prevotella species 16S rDNA multiple sequencing
Prevotella species oral clone DO033 16S rDNA multiple sequencing
in pus specimens obtained from 2 patients (10%), and detection
of this species was also noted in 3 previous reports [8, 30, 31].
M. faucium is even more fastidious [32] and has, to our knowl-
edge, never been reported in brain abscesses. The organisms
detected by PCR are most likely not false-positive results, be-
cause the negative controls remained negative in all PCR runs.
In addition, the detected organisms are not contemporarily
known to be general environmental contaminants, and they
were not detected in other clinical specimens analyzed at the
same time as the brain abscess pus specimens.
The observed increase in the repertoire of brain abscess–
causative organisms can be linked to molecular evidence for
fastidious—and yet-uncultured—organisms (table 3). We ob-
served 15 sequences that matched with contemporarily uncul-
tured bacteria that had previously been characterized among
anaerobic periodontal and intestinal flora. Fourteen sequences
belonged to the gram-negative bacilli Bacteroidetes phylum, and
1 sequence belonged to the gram-positive bacilli Firmicutes phy-
lum order Clostridiales. In a previous study of oral flora, it was
estimated that ∼50% of the present bacteria were uncultured
[33] and belonged to the Bacteroidetes and Firmicutes phyla.
High-throughput analyses of the bacteria associated with brain
abscess in our study revealed that the flora was even more
variable than expected, including 27 bacterial species found in
cerebral abscesses that have not been previously reported. Sim-
ilar results were observed in previous studies that used com-
parable tools and that investigated other infections, such as
endodontic infection, dental caries and periodontitis, and pul-
monary infection in patients with cystic fibrosis [16, 17, 34,
35]. Moreover, molecular approaches often permitted us to
associate M. faucium [32] with the development of brain ab-
scesses for the first time, because this species was observed in
3 patients. M. faucium is an inhabitant of the primate oro-
pharynx [36], and it was recently associated with chronic gas-
tritis in Korean patients [37]. Other species that were detected
in individual patients are normal inhabitants of the human oral
cavity, and they include Campylobacter gracilis [38], Mogibac-
terium timidum [39], Prevotella baroniae [40], Prevotella tan-
nerae [41], Peptostreptococcus stomatis [40], a new Neisseria
species [42], a new Capnocytophaga species that exhibits 99%
16S rDNA sequence similarity with 1 uncultured Capnocyto-
phaga species [38], and a new Prevotella species that exhibits
97.8% 16S rDNA sequence similarity with Prevotella shahii [43].
Compared with findings from the literature (table 2), 27 of the
49 species observed in our study have never before been re-
ported in brain abscesses.
In conclusion, our investigation has determined that the va-
riety of brain abscess–associated bacterial species is much larger
than has previously been reported, and it includes many an-
aerobes and uncultured bacteria from oral cavity flora. We have
confirmed the recently reported role of M. hominis, and we
report, for the first time, the role of M. faucium. Additional
studies and the data reported herein could potentially direct
modifications to current brain abscess antibiotic treatments.
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Preamble 
 
Brain abscesses are focal infections that can be caused by many 
different types of pathogens, mainly bacteria. Despite advances in 
diagnostic and neurosurgical procedures, the mortality of this disease 
remains high (8-32 %) [6, 9-11], and sequelae are observed in 9-36 % of 
patients [4, 11, 12]. 
Recently, amplification and sequencing of 16S rDNA has efficiently 
been applied to brain abscess specimens. However, the bacterial flora 
involved in this infection is often complex. In a previous study, using a 
metagenomic approach based on 16S rDNA amplification, we 
demonstrated that the diversity of the microbial flora involved in these 
infections was underestimated. This preliminary study identified 49 distinct 
brain abscess bacterial agents, and enabled the identification of 27 bacteria 
never detected before in brain abscess, 15 of which were uncultured. 
These results prompted the study of 51 new specimens in an effort to 
describe further the flora associated with brain abscesses and their 
etiologies. We performed a 16S rDNA-based metagenomic analysis of 
cerebral abscesses from 51 patients and the results were compared with 
those obtained from culture. Also, a univariate analysis was also performed 
to detect statistically-significant associations between cloning results, 
underlying disease and identified microorganisms. 
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In this study, by identifying 80 distinct bacterial taxa, including 44 
(55 %) never described in brain abscess previously, we demonstrated that 
the microbial flora of brain abscesses is far from being fully known, and is 
differentially distributed according to the abscess aetiology. From 80 taxa, 
22 were uncultured bacteria. These uncultured agents mostly originated 
from the buccal or sinusal floras and were found in polymicrobial 
specimens. Data mining discriminated two distinct bacterial populations in 
brain abscess from dental and sinusal origin.  
When combined with our previous study, metagenomic analysis of 
16S rDNA sequences amplified from brain abscesses from 71 patients 
proved to be an extremely powerful tool, identifying 71 bacterial taxa that 
had not been detected in these infections, including 37 that are as yet 
uncultured, and highlighting the sinusal and dental floras as the main 
source of new bacterial taxa in brain abscess, notably uncultured bacteria. 
Our results suggest that, cloning and sequencing of PCR-amplified 
16S rDNA is a highly valuable method to identify bacterial agents of brain 
abscesses.  
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Metagenomic analysis of brain abscesses identifies specific 
bacterial associations 
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ABSTRACT 
 
Purpose: Recently, amplification and sequencing of 16S rDNA has 
efficiently been applied to brain abscess specimens. However, the bacterial 
flora involved in this infection is often complex. In a previous study, using 
a metagenomic approach based on 16S rDNA amplification, we 
demonstrated that the diversity of the microbial flora involved in these 
infections was underestimated.  
 
Methods: Herein, in an effort to widen our understanding of the brain 
abscess flora, we performed a 16S rDNA-based metagenomic analysis of 
cerebral abscesses from 51 patients. Results: By detecting polymicrobial 
infections in 19 patients, our strategy was significantly more discriminatory 
and enabled the identification of greater number of bacterial taxa, than 
culture and conventional 16S rDNA PCR/sequencing, respectively                   
(p < 10
-2
). Data mining discriminated two distinct bacterial populations in 
brain abscess from dental and sinusal origin. In addition, of the 80 detected 
bacterial species, we identified 44 bacteria that had never been found in 
brain abscess specimens, including 22 uncultured bacteria. These 
uncultured agents mostly originated from the buccal or sinusal floras               
(p < 10
-2
) and were found in polymicrobial specimens (p < 10
-2
).  
 
Conclusions: Cloning and sequencing of PCR-amplified 16S rDNA is a 
highly valuable method to identify bacterial agents of brain abscesses.  
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INTRODUCTION 
 Brain abscesses are focal infections that can be caused by many 
different types of pathogens, mainly bacteria. Brain abscesses result from 
direct extension from a contiguous suppurative focus (paranasal sinuses, 
middle ear, mastoids) in 25-50 % of cases [1-3], from hematogenous 
dissemination from a distant focus in 15-30 % of cases [1, 2], or from 
direct inoculation (trauma or neurosurgery) in 8-19 % of cases [4]. 
However, in 20-30 % of cases, no source can be identified [2, 3]. 
Regardless of the causative pathogen, the brain tissue reacts and develops 
an area of focal cerebritis which progresses to an encapsulated abscess [3]. 
Brain abscesses occur at all ages, more frequently in men than in women 
[4-6]. Despite advances in diagnostic and neurosurgical procedures, the 
mortality of this disease remains high (8-32 %) [6-9], and sequelae are 
observed in 9-36 % of patients [4, 8, 10]. Currently, the detection of 
bacterial pathogens in brain abscesses is mostly obtained using culture 
from pus collected by neurosurgical drainage [11, 12]. However, pus 
culture remains sterile in 9-63 % of cases [5, 6, 10]. Over the past decade, 
16S rDNA amplification and sequencing was successfully used to detect 
bacteria in brain abscess specimens [13-15]. However, this method was 
impaired in cases of polymicrobial infection. In a recent study, Keller et al. 
added to 16S rDNA PCR a separation of PCR products by high-resolution 
polyacrylamide gel electrophoresis [16]. However, the discriminatory 
power of this method is limited to microorganisms that exhibit 16S rDNAs 
of different sizes. 
 In contrast, although more time-consuming, metagenomic studies of 
complex human floras using a combination of 16S rDNA PCR and cloning-
sequencing of PCR products proved useful to evaluate the bacterial 
diversity of dental, vaginal and intestinal floras [17-22]. In a previous 
study, we applied such an approach to brain abscess specimens [23]. This 
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preliminary study identified 49 distinct brain abscess bacterial agents, and 
enabled the identification of 27 bacteria never detected before in brain 
abscess, 15 of which were uncultured [23-25]. Such a high number of 
bacterial species involved in brain abscess prompted the study of 51 new 
specimens in an effort to describe further the flora associated with brain 
abscesses and their etiologies. 
 
MATERIALS AND METHODS 
Patients and clinical specimens 
 One pus specimen was obtained from each of 51 patients who 
underwent surgery for brain abscess in Marseille and Nice Hospitals from 
2006 to 2010. Pus specimens were collected in operating rooms equipped 
with laminar flow systems and HEPA filters, using sterile devices under 
aseptic surgical procedures, in sterile tubes, and immediately sent to the 
bacteriology laboratory for culture and molecular investigation. A brain 
abscess in this study was defined as a localized intra-cerebral suppurative 
lesion, visible on computerized tomography (CT) or magnetic resonance 
imaging (MRI) for which histological analysis confirmed the presence of 
pus and excluded the presence of cancerous and lymphomatous cells. The 
study was approved by the local Ethics Committee under reference 07-030. 
 
Culture 
 Upon reception, pus specimens were microscopically examined after 
Gram staining, and the presence of bacteria and polymorphonuclear 
leukocytes were noted. Specimens were then plated on blood and chocolate 
agar plates (BioMérieux, Marcy L’Etoile, France) and incubated at 37°C 
under aerobic and anaerobic atmospheres. Plates were examined daily for 
the presence of colonies for 10 days. Pure bacterial cultures, obtained by 
picking isolated colonies, were identified using the Vitek2 instrument and 
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API identification strips (BioMérieux). When phenotypic identification 
failed, isolates were identified using 16S rDNA sequencing as previously 
described [26]. 
 
Conventional 16S rDNA and 18S rDNA PCR amplification, and 
sequencing 
 For each specimen, a lysis step was performed by adding 200 µl of 
lysis buffer and 50 µl proteinase K to 100 µl of pus specimen. Incubation 
was performed overnight at 56 °C. The lysis product was then transferred 
to a tube containing glass powder, and agitation was obtained using the 
FastPrep instrument (BIO101 Systems, Savant, France).The tube was then 
incubated for 10 min at 100 °C. Total DNA was extracted from the sample 
using the MagNA Pure LC DNA isolation kit II and the MagNA Pure LC 
instrument (Roche, Meylan, France) according to the manufacturer’s 
instructions. Extracted DNA was recovered in 100 µl of water. 
 16S rDNA and 18S rDNA were amplified using the fD1-rp2 and 
CUF-CUR primer pairs, respectively (Table 1). For each PCR reaction, five 
µl of extracted DNA were amplified in a 50 µl reaction mixture containing 
5 U of AluI endonuclease (Invitrogen), 10 pmol of each primer 
(Eurogentec), 2 mM of each dATP, dCTP, dGTP and dTTP (Promega), 
1.25 U of HotStar Taq polymerase (Qiagen), 2 µl of a 25 mM solution of 
MgCl2 in 1 X Taq buffer (Qiagen). AluI (Rothman) was used to destroy any 
possible trace of contaminant DNA in the various reagents of the PCR mix. 
Either PCR mix (before addition of DNA) was incubated at 37°C for               
90 min, and then at 65 °C for 30 min to inactivate AluI. PCR amplifications 
were carried out in a 2720 Thermal Cycler (Applied Biosystem) under the 
following conditions: an initial 15-min denaturation step at 95°C,  followed 
by 35 cycles comprising denaturation for 1 min at 95 °C, annealing for 30 s 
at 52°C, and extension for 2 min at 72 °C. The amplification was 
 66 
completed by 7 min at 72 °C. 16S rDNA or 18S rDNA PCR products were 
purified using the NucleoFast 96 PCR kit (Macherey-Nagel) according to 
the manufacturer’s recommendations. Sequencing reactions were carried 
out using the Big-Dye Terminator, version 1.1, cycle sequencing kit DNA 
(Perkin-Elmer) according to the manufacturer’s instructions. 16S rDNA 
PCR products were sequenced in both direction using the following 
internal primers, 536f, 536r, 800f, 800r, 1050f and 1050r, whereas 18S 
rDNA amplicons were sequenced using the PCR primers (Table 1). Cycle 
sequencing was performed with a 2720 Thermal Cycler (Applied 
Biosystem) with an initial 1-min denaturation step at 96°C, followed by           
25 cycles of denaturation at 96 °C for 10s, annealing at 50 °C for 5s, and 
extension at 60 °C for 3 min. Sequencing products were purified and 
sequences were analyzed on an ABI PRISM 3130x Genetic Analyzer 
(Applied Biosystems, Foster City, USA). The different fragments were 
assembled using the sequencher software (Applied Biosystem). Obtained 
sequences were compared to the GenBank database using the BLAST 
software. 
 
Beta-globin gene amplification 
 Amplification of the Beta-globin gene was carried out to check the 
efficiency of DNA extraction and the possible presence of inhibitors in the 
samples that were negative by PCR amplification. The beta-globin gene 
was amplified using the primer pair KM29 and RS42 (Table 1), using the 
PCR conditions described for 16S rDNA amplification except that AluI was 
not added and that the annealing temperature was 62 C. 
 
16S rDNA cloning and sequencing 
 All 16S rDNA PCR-positive products were also cloned using the 
pGEM-T Easy Vector System with JM109 Competent Escherichia coli 
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according to the manufacturer’s instructions (Promega, Charbonnières, 
France). Transformed bacteria were grown over-night at 37 °C on plates 
containing 100 µl/ml ampicillin (Panpharma), 0.08 mg/ml X-Gal and              
0.12 mg/ml IPTG (Euromedex). For each sample, 100 white colonies were 
picked. Each colony was mixed with 100 µl sterile water, then 5 µl of this 
suspension was used for PCR amplification. Amplification was performed 
using the M13d and M13r primers (Table 1) and the following conditions: 
an initial 15-min denaturation step at 95°C followed by 40 cycles 
comprising denaturation for 1 min at 95°C, annealing for 30 s at 57°C, and 
extension for 2 min at 72°C. The final amplification was completed by                  
7 min at 72 °C. Electrophoresis in agar gel was performed to identify 
positive PCR products. Sequencing was performed as previously described 
using the 536r, 536f, 800f, 800r, 1050f, and 1050r primers (Table 1). 
 
Data analysis and taxa identification 
 Sequences obtained from each clone were compared to the GenBank 
database using the BLAST software (http://www.ncbi.nlm.nih.gov). A 
level of 98.7 % sequence similarity was used as the cut-off for species 
identification [27]. The libraries were checked for the presence of Chimeric 
sequences using the CHIMERA_ CHECK program of the Ribosomal 
Database Project II [28]. Chimeric sequences were excluded from this 
study. The complete 16S rDNA gene sequences representing a novel 
phylotypes were deposited in GenBank. The nucleotide accession numbers 
are listed in Table 3. 
 
Analysis of data 
 The data from the 51 patients in this study and the 20 patients from 
our previous study [23] were collected on an EXCEL spread sheet 
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(Microsoft) and analyzed with the PASW Statistics 17.0 software (Chicago, 
Illinois, USA) and the PASW modeler 14 software (PASW Statistics). 
 
Univariate analysis 
 A univariate analysis was performed to detect statistically-significant 
associations between cloning results, underlying disease and identified 
microorganisms. The Mantell-Haenszell or the Fisher exact tests were used 
according to the expected values of the cells. Differences between 
diagnostic methods were evaluated using the Fisher’s exact test. A p value 
< 0.05 was considered as significant. 
 
Data mining 
 The Auto Cluster node component of the PASW modeler (PASW 
Statistics) was used to estimate and compare clustering models, which 
identify groups of records that have similar characteristics without the 
benefit of prior knowledge about the groups and their characteristics. For 
the data mining analysis, because of the relatively small number of patients 
and microorganisms, these were grouped by genus or groups of bacteria 
(uncultured bacteria, other anaerobes, other streptococci, other 
staphylococci, enterobacteriaceae, -proteobacteria) and those isolated only 
once were omitted.   
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RESULTS  
Clinical Data 
 The 51 studied patients included 37 males (72%) and 14 females 
(28%). Forty-six were adults, and five were children. The age of patients 
ranged from 9 months to 87 years. The age, sex and epidemio-clinical data 
of patients are detailed in Table 2. Briefly, the abscess developed 
contiguously following chronic sinusitis in 11 patients (21.5%), otitis 
media in six patients (11.7%), dental infections or treatment in six patients 
(1.1 %), or neurosurgery in seven patients (13.7 %), in four patients with 
cancer (7.8 %), in three immunocompromised patients (5.9 %), and in 
various conditions in 11 patients (21.5 %). No primary source was 
identified in 3 patients (5.9 %). A microbiological diagnosis was obtained 
in 43 patients. A microbiological diagnosis was obtained in 43 patients 
(Table 2). 
 
Culture 
 Microorganisms were visible microscopically in 23 specimens               
(45.1 %) (Table 2). Culture was positive in 30 patients (59%) and sterile in 
21 (41%) (Table 2). Among the 30 culture-positive samples, 25 grew one 
bacterium, four grew 2 bacteria (Campylobacter rectus and Prevotella 
heparinolytica in one, Staphylococcus epidermidis and Streptococcus 
intermedius in one, and Haemophilus aphrophilus and Streptococcus 
intermedius in two), and one sample grew 3 bacteria (Enterococcus avium, 
Proteus mirabilis, and Bacteroides fragilis) (Table 2). The most common 
pathogens were S. intermedius isolated in 8 samples (including 3 in co-
culture with H. aphrophilus or S. epidermidis), Propionibacterium acnes in 
4 samples, H.  aphrophilus in 3 samples (including 2 in co-culture with               
S. intermedius), Staphylococcus aureus in 3 samples, and Enterobacter 
cloacae and Streptococcus pneumoniae in two samples each. Nocardia 
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abscessus, Klebsiella pneumoniae, Citrobacter koseri, Escherichia coli, 
Haemophilus parainfluenzae and Staphylococcus epidermidis, were 
isolated in pure culture from one sample each. Overall, 18 different species 
were detected by culture. The pathogens cultivated from pus samples are 
listed in Table 2.  
 
Conventional PCR and Sequencing 
 All 51 tested samples were PCR-positive using beta-globin 
amplification. 16S rDNA PCR was positive in 39 samples and 18S rDNA 
PCR in another four. Negative controls remained negative in all PCR 
experiments. In 7 samples, 16S rDNA sequencing identified polymicrobial 
infections but failed to discriminate among species. In 32 samples a single 
bacterium was detected by 16S rDNA sequencing, including S. intermedius 
(11 samples), P. acnes (4), S. pneumoniae (4), S. aureus (3), E. cloacae (2), 
and H. aphrophilus, H. parainfluenzae, N. abscessus, K. pneumoniae,                  
C. koseri, E. coli, Enterobacter sp., Fusobacterium nucleatum, and 
Nocardia carnea in one sample each. Overall, 14 different species were 
identified by conventional 16S rDNA sequencing. 18S rDNA PCR 
identified Toxoplasma gondii in three patients and Scedosporium 
apiospermium in one. The pathogens detected using 16S rDNA and 18S 
rDNA amplification and sequencing are listed in Table 2. 
 
16S rDNA-based metagenomic analysis 
 The 39 PCR-positive samples were cloned and analyzed. For each 
patient, 100 clones with an insert of the correct size (approximately 1,500 
base pairs) were analyzed. The percentage of chimeric insert in 16S rDNA 
gene libraries ranged from 0 to 5% depending of the sample and such 
sequences were excluded. Cloning results are reported in Tables 2 and 3. 
Polymicrobial infections were detected in 19 samples, and mono-microbial 
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infections in 20. Among the 19 polymicrobial specimens, the number of 
detected bacterial species ranged from 1 to 14. In all 20 mono-microbial 
specimens, cloning identified the same bacterium as conventional 16S 
rDNA sequencing. In total, 76 different species were identified, 23 of 
which exhibited a greatest sequence similarity to uncultured bacteria. The 
most commonly detected species where S. intermedius (12 samples),                 
F. nucleatum (8), M. micros (6), P. acnes (5), S. pneumoniae (4),                   
H. aphrophilus (4), S. aureus (3), Porphyromonas endodentalis,  
Eubacterium brachy, E. coli, Enterobacter hormaechi, and E. cloacae in              
2 samples each. Of the 76 identified species, 44 had not previously been 
identified in brain abscesses. These included 22 validated species and                
22 uncultured bacteria (Table 3). 
Comparison between diagnostic methods 
 The 30 culture-positive specimens were also PCR-positive. In 22 of 
these samples, the identified bacteria were identical using culture and 
conventional 16S rDNA sequencing. The remaining eight culture-positive 
samples included four specimens that were polymicrobial using 16S rDNA, 
three in which only one of the two cultivated bacteria was PCR-detected, 
and one in which the cultivated bacterium (S. constellatus) differed from 
that PCR-detected (F. nucleatum). Twelve specimens were negative using 
both PCR and culture (Table 2). Positive PCR and negative culture were 
observed in 9 specimens, including three that were polymicrobial using 
conventional sequencing, and six from which a single bacterium was 
detected (Table 2). 
 All bacterial species detected using conventional 16S rDNA 
sequencing were retrieved using 16S rDNA cloning and sequencing. In 
contrast, six bacterial species detected by culture methods from six 
specimens were not detected by cloning. These included both E. avium and 
P. mirabilis in one specimen, S. epidermidis in two specimens, and                     
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S. constellatus, C. rectus, and H. aphrophilus in one sample each (Table 2). 
Of the 80 bacterial taxa identified in this study, 16S rDNA cloning and 
sequencing detected 76 (95%), including 59 that were not detected by the 
other methods (73.7%) (Table 2). Cloning and sequencing identified 
significantly more polymicrobial specimens than culture (19/51 vs 5/51,                 
p < 10-2) and conventional sequencing (19/51 vs 7/51, p < 10-2). In addition, 
cloning and sequencing detected significantly more bacterial taxa than 
culture (76/80 vs 18/80, p < 10-2) and conventional sequencing (76/80 vs 
14/80, p < 10-2).  
Identification of disease-specific floras 
 The combination of data from 71 patients (51 from the present study 
and 20 from our previous study [23]) enabled the identification of several 
associations using the data mining analysis: sinusitis or dental defect with 
polymicrobial infections, in particular by Fusobacterium sp., 
Campylobacter sp. and Peptrostreptococcus sp., immunodeficiency with 
toxoplasmosis and Nocardia sp., and brain surgery with Pseudomonas sp., 
-proteobacteria and Micrococcus sp. 
 Univariate analysis demonstrated a significant association between 
polymicrobial infections and sinusitis or dental defects (18/29 vs 6/42,                  
p < 10-2), between polymicrobial infections and Streptococcus sp., 
Prevotella sp., Peptostreptococcus sp., Staphylococcus sp., Campylobacter sp., 
Fusobacterium sp., Porphyromonas sp., other anaerobes, Mycoplasma faucium 
and uncultured bacteria (p < 0.02 for all microorganisms). Monomicrobial 
infections were significantly associated with otitis media (6/29 vs 2/42,               
p = 0.04). 
 Sinusitis or dental defect were associated to Streptococcus sp., 
Prevotella sp., Peptostreptococcus sp., Streptococcus intermedius, 
Campylobacter sp., Fusobacterium sp., other anaerobes, Mycoplasma faucium 
 73 
and uncultured bacteria (p < 0.04 for all microorganisms). Brain surgery was 
associated to enterobacteriaceae and -proteobacteria (p < 0.02). 
 The presence of uncultured bacteria (9/24 vs 2/47, p < 10
-2
) and 
Mycoplasma faucium (4/24 vs 0/47, p < 10
-2
) was significantly associated 
to sinusitis or dental defect.  
 The PASW modeler autocluster node found that the K-means node 
clusters was the method that provided the best results for the identification 
of clusters in the database. The K-means method classified the patients into 
4 groups according to the demographic and clinical data as well as to the 
microorganisms isolated alone or in combination (Table 4). The first group 
included 49 (69%) patients, the second 18 (25.4%) patients, the third 3 
(4.2%) patients and the fourth only one patient. The first group included 
patients for whom only cultured bacteria were detected and most infections 
were monomicrobial, and patients without any aetiology identified.  In 
group 2, most patients had suffered sinusitis or dental treatments and had 
polymicrobial infections including uncultured bacteria in only 39% of 
cases. The most common identified microorganisms were 
Peptostreptococcus spp., Fusobacterium spp. and Streptococcus 
intermedius. In group 3, most patients had also suffered sinusitis and 
polymicrobial brain abscesses, but differed from group 2 by the systematic 
presence of Bacteroides spp. and uncultured bacteria, and of Mycoplasma 
faucium and Enterobacteriaceae in 2/3 patients. Group 4 was constituted 
by a single patient who developed, following brain surgery, a 
polymicrobial infection made of bacteria belonging to at least 5 different 
genera and/or species. No statistical link could be made between these 
microbial groups and clinical or epidemiological characteristics. 
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DISCUSSION 
 In this study, by identifying 80 distinct bacterial taxa, including            
44 (55 %) never described in brain abscess previously, we demonstrated 
that the microbial flora of brain abscesses is far from being fully known, 
and is differentially distributed according to the abscess aetiology. 
 In most laboratories microbiological documentation of brain 
abscesses primarily relies on direct microscopic examination and culture of 
abscess pus collected after neurosurgical drainage [5, 6, 10-12], with a 
limited diagnostic yield. In our study, culture on axenic media yielded 
bacteria in 30/51 (58.8 %) patients but only 18 distinct bacterial taxa, most 
of which had previously been described in brain abscesses, were identified. 
Such a low output may be due to early antibiotic use, delay between 
sampling and inoculation, and involvement of fastidious bacteria. In 
contrast to culture, 16S rDNA amplification and sequencing enables 
detection of bacteria in patients in whom antimicrobial therapy has been 
started before sampling or when specimen transport or culture are not 
optimal [13, 15, 29]. However, a major drawback of conventional 16S 
rDNA sequencing is its limited discriminatory power among taxa in 
complex floras. In particular, it often yields uninterpretable sequences, as 
previously described for brain abscess specimens [13, 15], and even the use 
of an extended electrophoresis step to separate PCR products prior to 
sequencing [30] may not separate those that exhibit a similar size. 
 Adding a cloning step of PCR products prior to sequencing enabled 
us to identify a significantly greater number of polymicrobial specimens 
and bacterial taxa (76) than culture (18) and conventional 16S rDNA 
sequencing (13) (p < 10
-2
 for both), as in our previous study [23]. The 
discrepancy observed between floras identified by culture and 
metagenomic approaches might be due to the fact that the most abundant 
microorganisms within a given specimen may be fastidious, with a 
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consequence being that culture may retrieve only those that are cultivable, 
irrespective of their abundance in the studied specimen [31]. Such a limit 
may be overcome by metagenomic methods. However, metagenomics may 
also suffer from several drawbacks. PCR primers may introduce biases into 
the analysis of the species composition of clone libraries because of 
mismatches between the primer and the target organism sequences [17]. 
We also acknowledge the fact that the number of sequenced clones may not 
enable characterization of all bacterial taxa present in the polymicrobial 
samples. In particular, it is possible that the specimens that we found to be 
monomicrobial contained a predominant bacterium and other under-
represented micro-organisms that were not detected.  
Our strategy enabled us to detect 44 bacteria (56.4%) that had not 
been identified previously in cerebral abscess. Similar results have been 
observed in our previous study [23] and in previous studies using 
comparable tools and investigating other infections, such as endodontic 
infections, dental caries and periodontitis, and pulmonary infections in 
cystic fibrosis patients [21, 22, 32, 33], thus demonstrating the power of 
metagenomic studies to characterize complex floras (Figure 1). In addition, 
data mining and statistical analyses demonstrated a strong association of 
polymicrobial infections and underlying sinusitis or dental defects                       
(p < 10-2). However, two groups were identified among patients with 
sinusitis or dental treatment (Table 4), including one made of 18 patients 
more likely to be infected with Peptostreptococcus spp., Fusobacterium 
spp. and/or Streptococcus intermedius but no uncultured bacteria, and a 
second group of 3 patients more likely to be infected with Bacteroides spp., 
uncultured bacteria, Mycoplasma faucium, and Enterobacteriaceae. 
Although we acknowledge the fact that the numbers of patients in both 
groups are small, we did not expect to identify two distinct microbial 
populations in brain abscesses following sinusitis or dental treatments. 
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These two distinct microbial populations were not associated to any 
epidemiological or clinical specificity. However, such a finding has 
implications on the management of patients, as M. faucium requires a 
specific antibiotic therapy that is not used in empirical treatment of brain 
abscess.  
Twenty-three sequences matched uncultured bacteria described as 
belonging to the periodontal or intestinal microflora. Only one of these 
(uncultured BA 21) had been detected previously in a brain abscess [23]. It 
is likely that these newly recognized agents of brain abscess were never 
cultivated from clinical specimens because of their fastidious nature, as 
previously described in metagenomic studies. The uncultured bacteria, 
including ten Bacteroidetes (43.5 %) and nine Firmicutes (39.1 %), were 
detected from seven specimens, and significantly associated to 
polymicrobial floras (p < 10
-2
), in particular in patients with a sinusal or 
dental risk factors (p < 10
-2
), thus highlighting the underestimated diversity 
of this potentially pathogenic human flora. In our previous metagenomic 
study of brain abscesses, uncultured bacteria were all Bacteroidetes or 
Firmicutes and also significantly associated to sinusal or dental infections 
(p =0.02) [23]. Our data are also consistent with published metagenomic 
studies of the oral flora, in which it was estimated that approximately 50 % 
of the bacteria are uncultivable [17, 17, 20-22, 34] and belong to the 
Bacteroidetes and Firmicutes phyla. 
 Mycoplasma faucium was identified in one specimen. In our previous 
study, M. faucium was detected in 3/20 specimens (15 %), which led us to 
think that it was quite a common brain abscess agent [23] and prompted the 
development of a specific PCR assay. However, in the present series, only 
one specimen was M. faucium-positive (1.9 %). This difference, which is 
nearly significant (p = 0.0.6), likely results from sampling differences. 
When combining data from both studies, we observed that M. faucium was 
 77 
significantly found in polymicrobial specimens (p = 0.02), in patients with 
sinusal or dental defects (p = 0.01).   
 Discordance between culture and biological results was observed in 
five samples. In one sample, S. constellatus was cultivated whereas 
sequencing 16S rDNA PCR product characterized F. nucleatum. 16S 
rDNA cloning and sequencing showed that the samples was polymicrobial 
but S. constellatus was not retrieved. In five samples (samples 2, 13, 16, 48, 
50), 6 bacterial species were cultivated but no corresponding clone was 
found. These bacteria were C. rectus, E. avium, P. mirabilis, 
Staphylococcus epidermidis, H. aphrophilus, and S. constellatus. Twelve 
samples were negative in both culture and 16S rDNA PCR. In four of these 
samples, all of which were obtained from immunocompromised patients, 
toxoplasmosis was diagnosed in three, and Scedospirum apiospermum 
infection in one. In the remaining eight samples no pathogen was 
identified. 
When combined with our previous study [23], metagenomic analysis 
of 16S rDNA sequences amplified from brain abscesses from 71 patients 
proved to be an extremely powerful tool, identifying 71 bacterial taxa that 
had not been detected in these infections, including 37 that are as yet 
uncultured, and highlighting the sinusal and dental floras as the main 
source of new bacterial taxa in brain abscess, notably uncultured bacteria. 
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Table 1: sequence of primers used for PCR and sequencing 
 
Primer / probe  
name 
Target Sequence (5’ 3’) 
fD1 16S rDNA gene 
amplification 
and sequencing 
AGA GTT TGA TCC TGG CTC AG 
rp2 ACG GCT ACC TTG TTA CGA CTT 
536r 
16S rDNA sequencing 
 
GTA TTA CCG CCG CTG CTG 
536f CAG CAG CCG CCG TAA TAC 
800f TAG ATA TAC CCG GTT AG 
800r CTA CCA GGG TAT CTA AT 
1050r CAC GAG CTG ACG ACA 
1050f 5’-TGT CGT CAG CTC GTG 
M13d 
Insert amplification 
CAG GAA ACA GCT ATG AC 
M13r GTA AAA CGA CGG CCA G 
KM29 
Beta-globin gene 
amplification 
GGT TGG CCA ATC TAC TCC CAG G 
RS42 GCT CAC TCA GTG TGG CAA AG 
CUF 18S rDNA gene 
amplification 
and sequencing 
TCCGTAGGTGAACCTGCGG 
CUR GCTGCGTTCTTCATCGATGC 
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Table 2: Characteristics of the 51 patients with brain abscess examined in this study and bacteria identified. 
 
 S
a
 A
b
 G
c
 AB
d
 
Risk 
factor 
Culture 
Conventional 
16S rDNA 
sequencing 
16S rDNA cloning and sequencing 
e
 
1 M 48 - - i - - 
g
 ND
 f
 
2 M 64 C+ - m Streptococcus 
constellatus 
Polymicrobial Micromonas micros (42), Prevotella buccae (10), Prevotella baroniae (18), 
Prevotella oris (12),  Uncultured BA10 (1), Uncultured  BA11 (1), 
Uncultured BA12 (2), Uncultured BA13 (1%), Uncultured BA14 (8), 
Uncultured BA15 (3), Uncultured BA16 (1), Uncultured BA17 (1), 
Uncultured BA18  (1), Uncultured BA19 (2).  
3 M 50 - - k Propionibacterium 
acnes 
P. acnes P. acnes (100) 
4 M 50 - - m Haemophilus 
parainfluenzae 
H. parainfluenzae H. parainfluenzae (100) 
5 F 51 C+ - m Streptococcus  
intermedius 
S. intermedius  S. intermedius (100) 
6 M 56 B+ - k Propionibacterium 
acnes 
P. acnes P. acnes (100) 
7 M 55 - - n Staphylococcus  aureus S. aureus S. aureus (100) 
8 F 87 B+ + l Propionibacterium 
acnes 
P. acnes P. acnes (100) 
9 M 38 - + l - S. pneumoniae S. pneumoniae (100) 
10 F 56 - + o Enterobacter cloacae E. cloacae  Enterobacter cloacae (57), Enterobacter hormaechei (40), Escherichia coli 
(3). 
11 F 25 B+ - o Propionibacterium 
acnes 
P. acnes P. acnes (100) 
12 M 41 C+ - l Streptococcus 
intermedius, 
Haemophilus 
aphrophilus  
 
S. intermedius  S. intermedius (70), H. aphrophilus (30). 
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13 F 81 - + k Prevotella 
heparinolytica, 
Campylobacter rectus  
Polymicrobial P. heparinolytica (96%), Fusobacterium nucleatum (4).  
14 M 57 - - p Nocardia abscessus  N. abscessus N. abscessus (95), Burkholderia cenocepacia (3), Stenotrophomonas 
maltophilia (2). 
15 F 1 - + l - S. pneumoniae  S. pneumoniae (100) 
16 H 40 B- - r Enterococcus avium, 
Proteus mirabilis, 
Bacteroides fragilis  
Polymicrobial Porphyromonas endodontalis (18), Porphyromonas asaccharolytica (2), 
Peptostreptococcus stomatis (8), Micromonas micros (12), Enterococcus 
raffinosus (2), Catonella morbi (1), B.  fragilis (30), Bacteroides 
thetaiotaomicron (12), Bilophila wadsworthia (8%), Uncultured BA20 (1), 
Uncultured BA21 (3), Uncultured BA22 (2), Uncultured BA23 (1). 
17 M 60 B- - o Kleibsiella. pneumoniae  K. pneumoniae K. pneumoniae (100) 
18 M 70 - - p - 
h
 - ND 
19 M 70 B- - k Citrobacter koseri  C. koseri C. koseri (100) 
20 F 61 C+ + q Streptococcus 
intermedius 
S. intermedius  S. intermedius (100) 
21 M 73 - - s -
 
- 
g
 ND 
22 M 54 - - m Haemophilus 
aphrophilus  
H. aphrophilus H. aphrophilus (95), Fusobacterium nucleatum (5). 
23 M 35 B- 
C+ 
- m Staphylococcus 
epidermidis 
Polymicrobial S. intermedius (2), Fusobacterium nucleatum (65), Campylobacter gracilis 
(6), Fusobacterium meyeri (6), Micromonas micros (17), Uncultured BA24 
(4). 
24 F 20 B- + o Escherichia coli E. coli E. coli 
25 M 48 - - t - - ND 
26 F 69 C+ + m - S. intermedius S. intermedius (100) 
27 M 57 - - p - Nocardia carnea N.  carnea 
28 M 62 - + m - Polymicrobial Tannerella forsythensis (20), Fusobacterium nucleatum (50), Porphyromonas 
endodontalis (11), Dialister pneumosintes (13), Propionibacterium acnes (2), 
Eubacterium brachy (1), Filifactor alocis (1), Uncultured BA25 (1), 
Uncultured BA26 (1). 
29 M 44 - - o - - ND 
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30 M 14 C+ - m Streptococcus 
intermedius 
S. intermedius  S. intermedius (93), Haemophilus aphrophilus (4), Fusobacterium nucleatum 
(3). 
31 M 12 C+ + l Streptococcus 
pneumoniae 
S.  pneumoniae S. pneumoniae (100) 
32 M 69  - - j - - ND 
33 F  75 - + u - - ND 
34 M 26 - + o Enterobacter cloacae Enterobacter sp. Enterobacter hormaechei  (98),  E. cloacae (1), Tepidimonas arfidensis (1). 
35 M 70 - + v - - ND 
36 F 44 - - o - - ND 
37 F  69 - - v - - ND 
38 M 55 - + l Streptococcus 
pneumoniae 
S. pneumoniae S. pneumoniae (100) 
39 M 23 - - i - - 
g
 ND 
40 M 38 C+ - w Streptococcus 
intermedius 
S. intermedius  S. intermedius (61), Micromonas micros (31), Eubacterium brachy (5), 
Fusobacterium nucleatum (3). 
41 M 42 C+ - j - Polymicrobial Campylobacter rectus (1), Treponema maltophilum (1), Bacteroides 
heparinolyticus (15), Porphyromonas gingivalis (33), Fusobacterium alocis 
(27), Fusobacterium nucleatum  (9), Eubacterium nodatum (4), 
Campylobacter showae (2),  Uncultured BA27 (8). 
42 M 54 - + o - Polymicrobial Clostridium cllostridiforme (27) ,  Massilia timonae (15), Uncultured BA28 
(9), Streptococcus parasanguinis (8), Pseudomonas trivialis (10), 
Micrococcus luteus (3), Enhydrobacter aerosaccus (1),  Petrobacter 
succinimandens (1),  Uncultured BA29 (12), Uncultured BA30 (1), 
Uncultured BA31 (13).   
43 M 58 C+ - m Streptococcus 
constellatus 
Fusobacterium  
nucleatum 
F. nucleatum (95), Haemophilus aphrophilus (5). 
44 F 84 - - v - - ND 
45 M 54 - + j - S. intermedius  S. intermedius (100) 
46 M 65 - - j - S. intermedius S. intermedius (67), Micromonas micros (34), Uncultured BA32 (7) 
47 F 9M C+ - x Staphylococcus aureus S. aureus S. aureus (100) 
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48 M 15 C+ - m Streptococcus 
intermedius, 
Staphylococcus 
epidermidis 
S. intermedius  S. intermedius (99), Pseudomonas lutae (1).  
49 M 36 C+ - y Staphylococcus aureus S. aureus S. aureus (100) 
50 M 47 C+ - m Streptococcus 
intermedius, 
Haemophilus 
aphrophilus 
S. intermedius  S. intermedius (97), Micromonas micros  (3). 
51 M 62 C+ - j Streptococcus 
intermedius 
S. intermedius  S. intermedius (95), M. faucium  (5). 
 
a S = sex; b A = age (y); c G = Gram staining, C+ = Gram-positive cocci, B+ = Gram-positive bacilli, B- = Gram-negative bacilli; 
d AB = antibiotic treatment prior to development of the abscess; e the number of clones per bacterium is indicated in parentheses; 
f ND = not done; g toxoplasmosis (positive 18S rDNA PCR); h  Scedosporium apiospermium infection (positive 18S rDNA 
PCR); i HIV-positive; j dental infection; k infection of brain metastasis from cancer; l otitis media; m chronic sinusitis; n skull base 
fracture and cerebro-spinal fluid rhinorrhea; o brain surgery within the past month; p renal graft recipient; q right lung pneumonia; 
r colic diverticulitis; s rheumatoid arthritis treated with rituximab; t Herpes simplex encephalitis; u acute pyelonephritis; v no risk 
factor identified; w dental treatment prior to cardiac surgery; x post-cardiac surgery; y venous catheter-associated bacteremia.
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Table 3: Bacterial species detected in 51 patients using 16S rDNA cloning and sequencing. Bacterial taxa were classified 
according to their previous identification or not in brain abscesses in the scientific literature. 
 
 
 
Previously reported taxa 
 
NP/NC 
 
Phylum  
 
Taxa never reported 
previously  
(GenBank accession 
number) 
 
Phylum 
 
NP/NC 
 
1 Streptococcus intermedius 11/890 Firmicutes 33 Enterobacter hormaechei Proteobacteria 3/138 
2 Fusobacterium nucleatum  8/234 Fusobacteria 34 Nocardia carnea Actinobacteria 1/100 
3 Micromonas micros 6/139 Firmicutes 35 Prevotella heparinolytica Bacteroidetes 1/96 
4 Propionibacterium acnes 5/402 Actinobacteria 36 Clostridium clostridiforme Firmicutes 1/27 
5 Streptococcus pneumoniae 4/400 Firmicutes 37 Fusobacterium alocis Firmicutes 1/27 
6 Haemophilus aphrophilus 4/134 Proteobacteria 38 Tannerella forsythensis Bacteroidetes 1/20 
7 Staphylococcus aureus 3/300 Firmicutes 39 Massilia timonae Proteobacteria 1/15 
8 Escherichia coli 2/103 Proteobacteria 40 Bacteroides heparinolyticus Bacteroidetes 1/15 
9 Enterobacter cloacae  2/58 Proteobacteria 41 Bacteroides 
thetaiotaomicron 
Bacteroidetes 1/12 
10 Porphyromonas 
endodontalis 
2/29 Bacteroidetes 42 Pseudomonas trivialis Proteobacteria 1/10 
11 Eubacterium brachy 2/6 Firmicutes 43 Streptococcus 
parasanguinis 
Firmicutes 1/8 
12 Citrobacter koseri 1/100 Proteobacteria 44 Eubacterium nodatum Firmicutes 1/4 
13 Haemophilus 
parainfluenzae 
1/100 Proteobacteria 45 Burkholderia cenocepacia Proteobacteria 1/3 
14 Kleibsiella pneumoniae 1/100 Proteobacteria 46 Porphyromonas 
asaccharolytica 
Bacteroidetes 1/2 
15 Nocardia abscessus 1/95 Actinobacteria 47 Enterococcus raffinosus Firmicutes 1/2 
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16 Porphyromonas gingivalis 1/33 Bacteroidetes 48 Campylobacter showae Proteobacteria 1/2 
17 Streptococcus constellatus 1/30 Firmicutes 49 Filifactor alocis Firmicutes 1/1 
18 Bacteroides fragilis  1/30 Bacteroidetes 50 Catonella morbi Firmicutes 1/1 
19 Prevotella baroniae 1 /18 Bacteroidetes 51 Pseudomonas lutea Proteobacteria 1/1 
20 Dialister pneumosintes 1/13 Firmicutes 52 Enhydrobacter aerosaccus Proteobacteria 1/1 
21 Prevotella oris  1/12 Bacteroidetes 53 Petrobacter 
succinimandens 
Proteobacteria 1/1 
22 Prevotella buccae 1/10 Bacteroidetes 54 Tepidimonas arfidensis Proteobacteria 1/1 
23 Peptostreptococcus 
stomatis 
1/8 Firmicutes 55 Uncultured BA 10 
(GU592680) 
Bacteroidetes  
24 Bilophila wadsworthia 1/8 Proteobacteria 56 Uncultured BA 11 
(GU592681) 
Bacteroidetes  
25 Campylobacter gracilis 1/6 Proteobacteria 57 Uncultured BA 12 
(GU592682) 
Bacteroidetes  
26 Actinomyces meyeri  1/6 Actinobacteria 58 Uncultured BA 13 
(GU592683) 
Firmicutes 1/1 
27 Micrococcus luteus 1/3 Actinobacteria 59 Uncultured BA 14 
(GU592684) 
Synergistetes 1/1 
28 Stenotrophomonas 
maltophilia 
1/2 Proteobacteria 60 Uncultured BA 15 
(GU592685) 
Firmicutes 1/2 
29 Campylobacter rectus 1/1 Proteobacteria 61 Uncultured BA 16 
(GU592686) 
Bacteroidetes 1/1 
30 Mycoplasma faucium 1/5 Tenericutes 62 Uncultured BA 17 
(GU592687) 
Bacteroidetes 1/8 
31 Treponema maltophilum 1/1 Spirochaetes 63 Uncultured BA 18 
(GU592688) 
Bacteroidetes 1/8 
32 Uncultured BA 21 
(GU592691) 
1/3 Firmicutes 64 Uncultured BA 19 
(GU592689) 
Bacteroidetes 1/3 
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    65 Uncultured BA 20 
(GU592690) 
Firmicutes 1/1 
    66 Uncultured BA 22 
(GU592692) 
Firmicutes 1/1 
    67 Uncultured BA 23 
(GU592693) 
Firmicutes 1/1 
    68 Uncultured BA 24 
(GU592694) 
Proteobacteria 1/2 
    69 Uncultured BA 25 
(GU592694) 
Bacteroidetes 1/1 
    70 Uncultured BA 26 
(GU592696) 
Bacteroidetes 1/2 
    71 Uncultured BA 27 
(GU592697) 
Firmicutes 1/1 
    72 Uncultured BA 28 
(GU592698) 
Firmicutes 1/4 
    73 Uncultured BA 29 
(GU592699)  
Firmicutes 1/1 
    74 Uncultured BA 30 
(GU592700) 
Bacteroidetes 1/1 
    75 Uncultured BA 31 
(GU592701) 
Proteobacteria 1/8 
    76 Uncultured BA 32 
(GU592702) 
Firmicutes 1/9 
 
NP = number of patients 
NC = number of clones 
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Table 4: Classification of the 71 patients according to data mining analysis. 
 Group 1 
N = 45 (69)*¶ 
Group 2 
N = 9 (25.4)* 
Group 3 
N = 5 (4.2)* 
Group 4 
N = 4 (1.4)* 
Microorganisms     
-proteobacteria No (2) No (0) No (0) Yes 
Bacteroides spp. No (0) No (0) Yes (100) No 
Enterobacteriacae spp. No (12) No (6) Yes (67) No 
Fusobacterium spp. No (2) Yes (67) No (33) No 
Micrococcus spp. No (0) No (0) No (0) Yes 
Mycoplasma faucium No (0) No (11) Yes (67) No 
Other anaerobes No (0) No (28) No (33) Yes 
Peptostreptococcus spp. No (0) Yes (61) No (33) No 
Porphyromonas No (0) No (17) No (33) No 
Pseudomonaceae No (0) No (0) No (0) Yes 
Pseudomonas spp. No (0) No (6) No (0) Yes 
S. intermedius No (16) Yes (56) No (33) No 
Uncultured bacteria No (0) No (39) Yes (100) Yes 
Polymicrobial infection No (14.3) Yes (100) Yes (100) Yes 
Demographic and clinical data 
Mean age (y) 49.6 50.4 48.7 54 
Male gender 67 89 100 Yes 
Brain surgery No (20) No (0) No (0) Yes 
Sinusitis or dental treatment No (12) Yes (89) Yes (67) No 
 
* In each column, percentages are indicated in parentheses.  
¶The seven patients for whom no aetiology was identified were all included in group 1. 
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Figure 1: Increasing number of bacterial taxa detected from brain abscesses over time, based on PubMed search.  
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Preamble 
Culture-independent approaches using 16S rRNA gene sequence 
clone library studies have demonstrated that approximately 50% of clones 
obtained from human oral cavity samples and 62–75% of clones obtained 
from human faecal and intestinal samples represent novel phylotypes [22, 
31, 32]. In addition to our previous studies, many studies based on 16S 
rRNA gene sequence comparisons have demonstrated that many uncultured 
bacteria are implicated in human infections [33, 34]. Anaerobic bacteria are 
part of the normal human microbiota and play an important role in the 
regulation of the immune system and nutrient processing [35], but they are 
also implicated frequently in human infections. 
These results prompted us to evaluate the possibility of isolation of 
uncultured bacteria. So, a specific media supplemented with antibiotic were 
used. Supernatant from anaerobic BACTEC bottles was inoculated into 
Schaedler broth supplemented with K3.  
To eradicate rapidly growing bacteria that would outgrow anaerobes, 
liquid medium was supplemented with antibiotics. Four tube types were 
prepared: the first tube was supplemented with vancomycin, the second 
tube was supplemented with kanamycin, the third tube was supplemented 
with both vancomycin and kanamycin; and no antibiotic was added to the 
fourth tube. Strain 7401987T was recovered after 10 days incubation under 
anaerobic conditions at 37°C from chocolate agar that had been inoculated 
with a sample from the kanamycin supplemented tube. Growth was tested 
using different media of which, BYP medium developed in our laboratory. 
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Based on 16S rRNA gene sequence comparisons and biochemical 
and chemotaxonomic analyses, our isolate represents a novel species in a 
new genus that is distantly related to members of the genera Bacteroides, 
Parabacteroides, Prevotella, Porphyromonas, Tannerella and 
Dysgonomonas. 
 
In this report, isolation of a novel Gram-negative anaerobic 
bacterium from a human brain abscess sample is described. 
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A strictly anaerobic bacterial strain, 7401987T, was isolated from a human brain abscess sample.
Cells were Gram-negative, non-spore-forming, coccoid to rod-shaped and motile by flagella in a
lophotrichous arrangement. The isolate was asaccharolytic and the major cellular fatty acids were
anteiso-C15 : 0 (28.2%), C16 : 0 (18.0%), iso-C15 : 0 (12.3%) and iso-C17 : 0 3-OH (11.7%). 16S
rRNA gene sequence comparisons showed that the isolate was distantly related to members of
the genera Bacteroides (,83.6% similarity), Parabacteroides (,79.9% similarity), Tannerella
(,79.8% similarity), Dysgonomonas (,79.6% similarity), Porphyromonas (,79.3% similarity)
and Prevotella (,78.9% similarity). The low 16S rRNA gene sequence similarity values and
physiological and biochemical characteristics differentiated strain 7401987T from all known
species and indicate that our isolate represents a novel species in a new genus within the phylum
Bacteroidetes. The name Phocaeicola abscessus gen. nov., sp. nov. is proposed; the type strain
of Phocaeicola abscessus is 7401987T (5CCUG 55929T 5CSUR P22T 5DSM 21584T).
Culture-independent approaches using 16S rRNA gene
sequence clone library studies have demonstrated that
approximately 50% of clones obtained from human oral
cavity samples and 62–75% of clones obtained from
human faecal and intestinal samples represent novel
phylotypes (Aas et al., 2005; Hayashi et al., 2002; Eckburg
et al., 2005). Studies based on 16S rRNA gene sequence
comparisons have demonstrated that many uncultured
bacteria are implicated in human infections (Fredricks
et al., 2005; Saito et al., 2006). Anaerobic bacteria are part
of the normal human microbiota and play an important
role in the regulation of the immune system and nutrient
processing (Hooper & Gordon, 2001), but they are also
implicated frequently in human infections. Gram-positive
anaerobic bacteria are classified in the phyla Firmicutes and
Actinobacteria. Gram-negative anaerobic bacteria are most
frequently clustered in the phylum Bacteroidetes. On the
basis of heterogeneity, Shah & Collins (1988, 1989, 1990)
divided the genus Bacteroides into three genera: (i)
Bacteroides, consisting of saccharolytic, non-pigmented
species; (ii) Prevotella, consisting of moderately sacchar-
olytic, bile-sensitive species; and (iii) Porphyromonas,
generally consisting of asaccharolytic, black-pigmented
species. Currently, the class ‘Bacteroidia’ includes four
families, Bacteroidaceae, ‘Porphyromonadaceae’, ‘Prevo-
tellaceae’ and ‘Rikenellaceae’; members are obligately anaer-
obic, Gram-negative, non-sporulating, pleomorphic rods.
In this report, isolation of a novel Gram-negative anaerobic
bacterium from a human brain abscess sample is described.
Based on 16S rRNA gene sequence comparisons and
biochemical and chemotaxonomic analyses, our isolate
represents a novel species in a new genus that is distantly
related to members of the genera Bacteroides, Para-
bacteroides, Prevotella, Porphyromonas, Tannerella and
Dysgonomonas.
A 76-year-old woman underwent neurosurgical interven-
tion after cancer of the face. Over a period of 3 days, she
developed fever, consciousness alterations and aphasia.
Magnetic resonance imaging and computerized tomo-
graphy revealed a left frontal brain abscess with oedema.
One day later, the patient underwent drainage of the
abscess. A pus specimen recovered from the patient was
sent to our laboratory in aerobic and anaerobic BACTEC
blood culture bottles for culture and molecular investi-
gations.
Supernatant from anaerobic BACTEC bottles was inocu-
lated into Schaedler broth supplemented with K3
(bioMe´rieux). To eradicate rapidly growing bacteria that
would outgrow anaerobes, liquid medium was supplemen-
ted with antibiotics. Four tube types were prepared: the
first tube was supplemented with 0.0075 g vancomycin l21;
the second tube was supplemented with 0.10 g kanamycin
The GenBank/EMBL/DDBJ accession number for the 16S rRNA gene
sequence of Phocaeicola abscessus strain 7401987T is EU694176.
16S rRNA gene sequence similarities between strain 7401987T and
members of some of the most closely related genera are available as
supplementary material with the online version of this paper.
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l21; the third tube was supplemented with both vancomy-
cin and kanamycin; and no antibiotic was added to the
fourth tube. Tubes were incubated at 37 uC and examined
daily for bacterial growth. When the media were turbid,
they were used to inoculate 5% sheep blood agar and
chocolate agar plates (bioMe´rieux), which were then
incubated anaerobically at 37 uC. Plates were inspected
every 5 days. Strain 7401987T was recovered after 10 days
incubation under anaerobic conditions at 37 uC from
chocolate agar that had been inoculated with a sample
from the kanamycin-supplemented tube.
Growth was tested on chocolate agar, 5% blood agar,
tryptic soy agar and 5% blood Schaedler agar
(bioMe´rieux). Growth was positive only on chocolate agar
plates after 5 days incubation; growth was not observed
after 15 days on the other media tested. Surface colonies on
chocolate agar after 7 days incubation at 37 uC under
anaerobic conditions were white, circular, regular, smooth,
shiny, convex and 1 mm in diameter. Growth was also
tested in BYP medium developed in our laboratory. The
composition of the medium was as follows: brain-heart
infusion agar (10 g l21), yeast extract (10 g l21), meat
peptone (5 g l21), casein peptone (5 g l21), starch (2 g
l21), D-glucose (2.5 g l21), NaCl (2.5 g l21), KH2PO4 (1 g
l21), Na2HPO4 (3 g l
21), haemin (0.025 g l21), vitamin K1
(0.01 g l21) and a vitamin/mineral mixture comprising
vitamin A (500 IU l21), vitamin D3 (40 IU l
21), vitamin B1
(2 mg l21), vitamin B2 (2 mg l
21), vitamin B6 (0.2 mg
l21), vitamin B12 (0.6 mg l
21), vitamin B3 (2 mg l
21),
vitamin C (6 mg l21), vitamin E (5 mg l21), folic acid
(0.3 mg l21), calcium pantothenate (3 mg l21), iron
(ferrous fumarate; 1.5 mg l21), magnesium sulfate
(0.5 mg l21) and calcium phosphate (10 mg l21).
Growth was positive in this medium after 5 days
incubation at 37 uC in an anaerobic atmosphere. Growth
of the isolate was tested under anaerobic and microaer-
ophilic conditions generated with the GENbag anaer and
GENbag microaer systems, respectively (bioMe´rieux).
Growth was also tested in the presence of air and 5%
CO2. The strain was strictly anaerobic and did not grow in
air, 5% CO2 or microaerophilic atmospheres. Different
growth temperatures (25, 30, 37, 45 and 50 uC) were tested;
growth occurred between 30 and 37 uC. Optimum growth
was observed at 37 uC.
The size and ultrastructure of the cells were determined by
transmission electron microscopy. Cells were grown on
Schaedler broth for 7 days. A bacterial suspension was pre-
fixed in 5% (v/v) glutaraldehyde in phosphate buffer
(Gibco) for at least 1 h at room temperature, washed in the
same buffer and stained with 1% (w/v) phosphotungstic
acid. Samples were examined on a Morgagni 268D
(Philips) electron microscope at an operating voltage of
60 kV. Coccoid and rod-shaped bacteria were observed.
After 7 days growth in Schaedler broth, 7% cells were rods
(1.7–0.4 mm wide and 1.2–6.5 mm long) and 93% cells
were coccoid (0.3–0.6 mm wide and 0.4–0.9 mm long)
(Fig. 1). Catalase activity, determined by the ID colour
catalase test kit (bioMe´rieux), was negative. Oxidase
activity was negative as determined by applying cells to
moistened discs that were impregnated with dimethyl-p-
phenylene diamine (bioMe´rieux). A mobility test, per-
formed after 8 days incubation in Schaedler broth, was
positive. API ZYM, API Rapid ID 32A and API 50CH strips
combined with API 50CHB/E (all bioMe´rieux) were used
for biochemical tests according to the manufacturer’s
instructions. Additional biochemical characteristics were
also obtained using the Biolog system. Bacterial growth was
observed on chocolate agar plates (bioMe´rieux) and cells
were suspended in AN inoculation fluid sterile (Biolog) to
a density of 0.35 and transferred to AN Microplates
(Biolog) as described by the manufacturer. Incubation was
carried out at 37 uC under an anaerobic atmosphere for
24 h. Acid was not produced from any of the carbohy-
drates tested. Results for strain 7401987T are given in the
species description.
Resistance to bile was verified by growing the bacteria on
BYP medium supplemented with 2% (w/v) dehydrated gall
salt (bile sac powder; MP Biomedicals) equivalent to 20%
(v/v) bile. The strain was susceptible to bile.
Fig. 1. Transmission electron micrographs of cells of strain
7401987T. The lophotrichous flagellar arrangement is noted in
the coccoid (a; bar, 200 nm) and rod (b; bar, 1 mm) forms.
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Preparation and determination of cellular fatty acids were
carried out by following a highly standardized method
similar to the Sherlock Microbial Identification system
(MIDI). The major cellular fatty acids were anteiso-C15 : 0
(28.2%), C16 : 0 (18.0%), iso-C15 : 0 (12.3%), iso-C17 : 0 3-
OH (11.7%), a mixture of C18 : 2v6,9c and anteiso-C18 : 0
(6.7%), C15 : 0 (6.2%), C16 : 0 3-OH (4.4%), C18 : 0 (3.0%),
C18 : 1v9c (2.5%) and C17 : 0 3-OH (2.1%).
Differential characteristics of strain 7401987T and some
related taxa are shown in Table 1.
Matrix-assisted laser-desorption/ionization time-of-flight
(MALDI-TOF) MS protein analysis was carried out. A
smear of bacterial material was deposited on each spot of a
polished-steel target plate. After air-drying, 1.5 ml matrix
solution (saturated solution of a-cyanohydroxycinnaminic
acid in 50% aqueous acetonitrile containing 2.5%
trifluoroacetic acid) per spot was applied. MALDI-TOF
MS was conducted using the Autoflex II MS (Bruker
Daltonics). All spectra were recorded in linear, positive-ion
mode. The acceleration voltage was 20 kV. Spectra were
collected as a sum of 675 shots across a spot. The
manipulation was repeated six times. Preprocessing and
identification steps were performed using the manufac-
turer’s parameters. Spectra were compared with the
existing bank in the BIOTYPER software. No significant
score was obtained, thus confirming that our isolate was
not a member of a known species and, potentially, was not
a representative of any known genus. A consensus
spectrum was produced and a taxonomic tree was obtained
by the principal component analysis clustering method
(Fig. 2).
Bacterial DNA was extracted using the MagNA Pure LC
DNA isolation kit III (Roche) with the MagNA Pure LC
instrument as described by the manufacturer. The 16S
rRNA gene of the isolated strain was amplified by PCR
using the universal primer pair fD1 and rp2 (Weisburg et
al., 1991).The amplified products were purified using the
NucleoFast 96 PCR kit (Macherey-Nagel) according to the
manufacturer’s recommendations. A BigDye Terminator
cycle sequencing kit (Applied Biosystems) and ABI PRISM
3130X Genetic Analyzer (Applied Biosystems) were used
for sequencing according to the manufacturer’s instruc-
tions. The different fragments were assembled using
SEQUENCHER software (Applied Biosystems). The sequence
obtained was compared with those in GenBank by using
BLAST through the NCBI server and similarities were
determined. Gene sequences were aligned using the multi-
sequence alignment program CLUSTAL_X version 1.8.
Phylogenetic relationships with closely related species were
determined using MEGA version 4 (Tamura et al., 2007).
Distance matrices were determined following the assump-
tions described by Kimura (1980) and were used to
elaborate dendrograms using the neighbour-joining
method (Saitou & Nei, 1987). The maximum-parsimony
algorithm was also used to infer phylogenetic relationships.
A bootstrap analysis was performed to investigate the
stability of the tree obtained. Bootstrap values were
obtained for a consensus tree based on 100 randomly
Table 1. Differential characteristics of strain 7401987T (Phocaeicola abscessus gen. nov., sp. nov.) and some related genera
Reference genera: 1, Bacteroides (data from Shah & Collins, 1989); 2, Prevotella (Willems & Collins, 1995a); 3, Dysgonomonas (Hofstad et al., 2000);
4, Porphyromonas (Willems & Collins, 1995b); 5, Parabacteroides (Sakamoto & Benno, 2006); 6, Tannerella (Sakamoto et al., 2002).+, Positive; 2,
negative; V, variable; ai-, anteiso-branched; i-, iso-branched.
Characteristic Strain 7401987T 1 2 3 4 5 6
Growth in bile 2 + 2 + 2 + 2
Aerobic growth 2 2 2 + 2 2 2
Mobility + 2 2 2 2 2 2
Pigment 2 2 V 2 +* 2 2
Catalase production 2 V V V V V V
Aesculin hydrolysis 2 V V V 2 + +
Indole production 2 V V V V 2 V
Nitrate reduction 2 2 2 2 2 2 +
Optimum growth
temperature (uC)
37 37 37 35 37 37 37
Time for visible growth 7 days 48 h 48 h 48 h 48 h 48 h 48 h
Major cellular fatty
acids
ai-C15 : 0, C16 : 0,
i-C15 : 0, i-C17 : 0
3-OH
ai-C15 : 0,
i-C17 : 0 3-OH,
i-C15 : 0, C16 : 0
ai-C15 : 0,
i-C17 : 0 3-OH,
i-C15 : 0, C16 : 0
ai-C15 : 0, C16 : 0,
i-C14 : 0, C16 : 0
3-OH
ai-C15 : 0,
i-C15 : 0
ai-C15 : 0,
i-C17 : 0 3-OH,
C18 : 1v9c, i-C15 : 0
ai-C15 : 0, C16 : 0
3-OH, i-C17 : 0
3-OH, C16 : 0
MetabolismD NF F MF F NF F NF
Principal source Brain abscess Faeces Oral cavity Human clinical
specimens
Oral cavity Faeces Periodontal
pockets
*Porphyromonas catoniae does not produce a black pigment on blood agar.
DF, Fermentative; MF, moderately fermentative; NF, non-fermentative.
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generated trees. The tree organization was the same using
the two methods (Fig. 3).
The 16S rRNA gene sequence of strain 7401987T showed
similarities of 99.6, 99.8, 99.9, 99.6 and 99.6% to sequences
of five previously described uncultured bacteria (GenBank
accession nos AM419955, AF481203, AY005066, EF192781
and DQ633518, respectively) from noma patients, endo-
dontic infection, subgingival plaque, dental implants and
diseased distal oesophagus, respectively.
16S rRNA gene sequence comparisons revealed that strain
7401987T was distantly related to members of the genus
Bacteroides (the most closely related type strain was
Bacteroides vulgatus ATCC 8482T, with 83.6% similarity).
All 16S rRNA gene sequences from known species from the
genus Bacteroides were retrieved from GenBank. These
sequences were aligned with the newly determined sequence
of strain 7401987T and sequence similarity values were
determined by using the program BIOEDIT (Hall, 1999).
Similarities ranged from 83.6% with B. vulgatus ATCC
8482T to 68.3% with Bacteroides coagulans ATCC 29798T.
Similarity values were determined between strain 7401987T
and the most closely related members of the genera
Porphyromonas, Prevotella, Dysgonomonas, Tannerella,
Anaerophaga and Parabacteroides and are presented in
Supplementary Table S1 (available in IJSEM Online).
Fig. 2. Mean spectra projection (MSP) den-
drogram generated by BIOTYPER software
(version 2; Bruker Daltonics) showing the
similarity of MALDI-TOF mass spectra of strain
7401987T and representatives of the genera
Bacteroides and Prevotella.
Fig. 3. Phylogenetic tree showing the position
of Phocaeicola abscessus 7401987T within
the ‘Bacteroidales’. The tree was constructed
by using the neighbour-joining method based
on 16S rRNA gene sequences (1425 nt
fragment). Numbers at nodes are proportions
of 100 resamplings that support the topology
shown; bootstrap values .50% are indicated.
The sequence of Bacillus cereus ATCC
10987 was used as the outgroup. Bar, 0.05
changes per nucleotide position.
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Based on phenotypic characteristics and phylogenetic
analyses, a novel species in a new genus, Phocaeicola
abscessus gen. nov., sp. nov., is proposed.
Description of Phocaeicola gen. nov.
Phocaeicola (Pho.cae.i.co9la. L. n. Phocaea a maritime town
of Ionia, modern-day Foc¸a in Turkey; L. suff. -cola
inhabitant, dweller; N.L. masc. n. Phocaeicola an inhabitant
of Phocaea).
Cells are Gram-negative, strictly anaerobic, non-spore-
forming, motile coccobacilli with lophotrichous flagella
arrangement. Catalase- and oxidase-negative. Susceptible
to bile. Asaccharolytic and non-pigmented. Member of the
order ‘Bacteroidales’. The type species is Phocaeicola
abscessus.
Description of Phocaeicola abscessus sp. nov.
Phocaeicola abscessus (abs.ces9sus. L. gen. n. abscessus of an
abscess).
Displays the following properties in addition to those given
in the genus description. After 7 days growth in Schaedler
broth, 7% cells are rods (1.7–0.4 mm wide and 1.2–6.5 mm
long) and 93% cells are coccoid (0.3–0.6 mm wide and 0.4–
0.9 mm long). The optimum temperature for growth is
37 uC. After 7 days growth on chocolate agar, colonies are
white, entire, circular, regular, smooth, shiny, convex and
1 mm in diameter. Using API ZYM, alkaline phosphatase,
acid phosphatase, naphthol-AS-BI-phosphohydrolase, a-
galactosidase, b-galactosidase, N-acetyl-b-glucosaminidase
and a-fucosidase activities are detected. Leucine arylami-
dase and a-glucosidase activities are weakly positive.
Esterase (C4), esterase lipase (C8), lipase (C14), valine
arylamidase, cystine arylamidase, trypsin, a-chymotrypsin,
b-glucuronidase, b-glucosidase and a-mannosidase activ-
ities are not detected. Using API Rapid ID 32A, positive
reactions are obtained for a-galactosidase, b-galactosidase,
b-galactosidase 6-phosphate, a-glucosidase (weakly pos-
itive with API ZYM), N-acetyl-b-glucosaminidase, alkaline
phosphatase, leucyl glycine arylamidase and alanine
arylamidase. Weakly positive reactions are obtained for
b-glucosidase, a-arabinosidase, arginine arylamidase and
leucine arylamidase. Negative reactions are obtained for
urease, arginine dihydrolase, b-glucuronidase, mannose
and raffinose fermentation, glutamic acid decarboxylase,
reduction of nitrate, indole production, proline arylami-
dase, phenylalanine arylamidase, pyroglutamic arylami-
dase, tyrosine arylamidase, glycine arylamidase, histidine
arylamidase, glutamyl glutamic acid arylamidase and serine
arylamidase. Using API 50CH, all reactions are negative.
Using the Biolog AN system, positive for utilization of
dextrin, D-glucose 6-phosphate, D-malic acid, pyruvic acid,
pyruvic acid methyl ester, succinamic acid, succinic acid,
succinic acid monomethyl ester, L-alanyl-L-glutamine, L-
glutamic acid, L-glutamine and glycyl L-glutamine, weakly
positive for utilization of L-fucose, a-D-glucose 1-phos-
phate and trehalose and negative for utilization of N-
acetyl-D-galactosamine, N-acetyl-D-glucosamine, N-acetyl-
b-D-mannosamine, adonitol, amygdalin, D-arabitol, arbu-
tin, cellobiose, a-cyclodextrin, b-cyclodextrin, dulcitol, i-
erythritol, D-fructose, D-galactose, D-galacturonic acid,
gentiobiose, D-gluconic acid, D-glucosaminic acid, a-D-
glucose, glycerol, DL-a-glycerol phosphate, myo-inositol, a-
lactose, lactulose, maltose, maltotriose, D-mannitol, D-
mannose, melezitose, melibiose, 3-methyl-D-glucose,
methyl a-D-galactoside, methyl b-D-galactoside, methyl a-
D-glucoside, methyl b-D-glucoside, palatinose, raffinose, L-
rhamnose, salicin, D-sorbitol, stachyose, sucrose, turanose,
acetic acid, formic acid, fumaric acid, glyoxylic acid, a-
hydroxybutyric acid, b-hydroxybutyric acid, itaconic acid,
a-ketobutyric acid, a-ketovaleric acid, DL-lactic acid, L-
lactic acid, D-lactic acid methyl ester, L-malic acid,
propionic acid, D-saccharic acid, m-tartaric acid, urocanic
acid, alaninamide, L-alanine, L-alanyl L-histidine, L-alanyl
L-threonine, L-asparagine, glycyl L-aspartic acid, glycyl L-
methionine, glycyl L-proline, L-methionine, L-phenylala-
nine, L-serine, L-threonine, L-valine, L-valine plus L-aspartic
acid, 29-deoxyadenosine, inosine, thymidine, uridine, TMP
and UMP. The major cellular fatty acids are anteiso-C15 : 0,
C16 : 0, iso-C15 : 0 and iso-C17 : 0 3-OH.
The type strain is 7401987T (5CCUG 55929T 5CSUR
P22T 5DSM 21584T), isolated from a human brain abscess
sample.
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Preamble 
 
Staphylococci are ubiquitous bacteria in nature that are able to 
colonize or infect a wide range of animals. During the last decade, several 
coagulase-negative staphylococci have been isolated from animals [36, 37], 
and clinical samples [38, 39]. In this report, we describe a novel coagulase-
negative species belonging to the genus Staphylococcus that was isolated 
from a human brain abscess sample. The brain abscess was formed as a 
complication of neurosurgical intervention for the treatment of a brain 
tumour. 
The isolate was identified using a Vitek 2 instrument and Gram-
positive card (bioMe´rieux) as Leuconostoc mesenteroides subsp. cremoris 
with a probability of 93 %. API 20 Staph strip inoculation was performed 
and an identification of Kocuria varians was obtained. 16S rRNA gene 
sequence determination was conducted and a comparison with the 
GenBank database showed that strain was a member of the genus 
Staphylococcus.  
Based on cellular morphology and biochemical criteria, the new 
isolate was assigned to the genus Staphylococcus, although it did not 
correspond to any recognized species. Phylogenetic analysis based on 16S 
rRNA gene sequence comparisons showed that the new isolate was most 
closely related to Staphylococcus piscifermentans, Staphylococcus 
condimenti, Staphylococcus carnosus subsp. carnosus, S. carnosus subsp. 
utilis and Staphylococcus simulans. Comparison of tuf, hsp60, rpoB, dnaJ 
and sodA gene sequences was also performed. 
On the basis of phenotypic and genotypic data, this isolate represents 
a novel species for which the name Staphylococcus massiliensis sp. nov. 
was proposed.  
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Gram-positive, catalase-positive, coagulase-negative, non-motile, non-fermentative and
novobiocin-susceptible cocci were isolated from a human brain abscess sample (strain
5402776T). This novel strain was analysed by a polyphasic taxonomic approach. The respiratory
quinones detected were MK-7 (93%) and MK-6 (7%) and the major fatty acids were C15 : 0 iso
(60.5%), C17 : 0 iso (8.96%) C15 : 0 anteiso (7.93%) and C19 : 0 iso (6.78%). The peptidoglycan
type was A3a L-Lys-Gly2-3–L-Ser-Gly. Based on cellular morphology and biochemical criteria, the
new isolate was assigned to the genus Staphylococcus, although it did not correspond to any
recognized species. The G+C content of the DNA was 36.6 mol%. Phylogenetic analysis based
on 16S rRNA gene sequence comparisons showed that the new isolate was most closely related
to Staphylococcus piscifermentans, Staphylococcus condimenti, Staphylococcus carnosus
subsp. carnosus, S. carnosus subsp. utilis and Staphylococcus simulans (97.7%, 97.6%,
97.6%, 97.6% and 96.5% sequence similarity, respectively). Comparison of tuf, hsp60, rpoB,
dnaJ and sodA gene sequences was also performed. In phylogenetic analysis inferred from tuf,
dnaJ and rpoB gene sequence comparisons, strain 5402776T clustered with Staphylococcus
pettenkoferi (93.7%, 82.5% and 89% sequence similarity, respectively) and on phylogenetic
analysis inferred from sodA gene sequence comparisons, it clustered with Staphylococcus
chromogenes (82.8%). On the basis of phenotypic and genotypic data, this isolate represents a
novel species for which the name Staphylococcus massiliensis sp. nov. is proposed (type strain
5402776T5CCUG 55927T5CSUR P23T).
Staphylococci are ubiquitous bacteria in nature that are
able to colonize or infect a wide range of animals.
Currently the genus Staphylococcus consists of more than
50 recognized species and subspecies. Coagulase-positive
Staphylococcus aureus subsp. aureus and coagulase-negative
staphylococci are among the most commonly isolated
bacterial species in the clinical microbiology laboratory.
Coagulase-negative staphylococci have long been regarded
as skin commensals and their role as pathogens has been
recognized only recently, especially in patients with
indwelling devices such as prosthetic valves and catheters
(Huebner & Goldmann, 1999; Von Eiff et al., 2002).
During the last decade, several coagulase-negative
staphylococci have been isolated from animals (Pantu˚cˇek
et al., 2005; Spergser et al., 2003) and clinical samples
(Tru¨lzsch et al., 2007; Zakrzewska-Czerwinska et al., 1995).
In this report, we describe a novel coagulase-negative
species belonging to the genus Staphylococcus that was
isolated from a human brain abscess sample.
In December 2005, a 52-year-old man underwent
neurosurgical intervention for the treatment of a brain
tumour. He developed fever, headache and an aggravation
of existing neurological symptoms. Magnetic resonance
imaging and computerized tomography revealed a frontal
brain abscess. Antibiotic therapy was begun with a
combination of imipenem, gentamicin and vancomycin.
The abscess was drained and samples of the pus were sent to
our laboratory for cultural and molecular investigations. A
bacterial strain was isolated on blood agar at 37 uC in an
aerobic atmosphere. Gram staining revealed Gram-positive
cocci that occurred singly, in pairs and in clusters. The
isolate (strain 5402776T) was identified using a Vitek 2
instrument and Gram-positive card (bioMe´rieux) as
Leuconostoc mesenteroides subsp. cremoris with a probability
of 93%. API 20 Staph strip inoculation (bioMe´rieux) was
performed and an identification of Kocuria varians was
obtained. 16S rRNA gene sequence determination was
conducted and a comparison with the GenBank database
showed that strain 5402776T was a member of the genus
Staphylococcus. It was initially suspected to be a contaminant
because it was sensitive to gentamicin and vancomycin.
The GenBank/EMBL/DDBJ accession number for the 16S rRNA
sequence of Staphylococcus massiliensis sp. nov. 5402776T is
EU707796.
Additional phylogenetic trees based on tuf, hsp60, rpoB, dnaJ and sodA
gene sequences are available as supplementary figures with the online
version of this paper.
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Antimicrobial susceptibility was determined according to
the CLSI (formerly National Committee for Clinical
Laboratory Standards; NCCLS) criteria. The novel isolate
was sensitive to oxacillin, gentamicin, clindamycin, oflox-
acin, rifampicin, fosfomycin, vancomycin, teicoplanin and
trimethoprim/sulfamethoxazole. The strain showed inter-
mediate susceptibility to fusidic acid.
Colony morphology and haemolytic activity were observed
after 48 h growth on 5% sheep blood agar at 37 uC.
Colonies were white, glossy, circular, bulging, non-
haemolytic and 1–3 mm in diameter. Growth was tested
at different temperatures (25, 30, 37, 45 and 50 uC) using
sheep blood agar. Growth occurred between 25 uC and
45 uC, but optimum growth was obtained at 37 uC. Growth
was tested in an anaerobic atmosphere created using the
GENbag anaer incubation system (bioMe´rieux), a micro-
aerophilic atmosphere created using the GENbag microaer
incubation system, in the presence of air and also in the
presence of 5% CO2. Growth occurred in all atmospheres
but was weak in microaerophilic and anaerobic atmo-
spheres. Growth in different NaCl concentrations was
tested in trypticase soy broth (TSB; Becton Dickinson)
supplemented with 2, 5, 7, 10 and 15% (w/v) NaCl. The
novel strain was able to grow in NaCl concentrations from
2% to 15% (w/v).
The size and ultrastructure of the cells were determined by
electron microscopy. Cells were grown in liquid TSB
medium for 48 h at 37 uC and stained with 1% (w/v)
phosphotungstic acid. The samples were examined using a
transmission electron microscope (Morgagni 268D;
Philips) at an operating voltage of 60 kV. The cells were
cocci of 0.5–0.8 mm in diameter.
Coagulase activity was investigated using Staph Aureus
Fumouze kit (Fumouze Diagnostics) and was negative.
Catalase activity was determined by the ID colour catalase
test kit (bioMe´rieux) and was positive. Oxidase activity was
assayed by applying the cells to moistened discs impreg-
nated with dimethyl-p-phenylene diamine (bioMe´rieux)
and was negative. Clumping factor activity was investigated
using the Slidex Staph Plus test (bioMe´rieux) and was
negative. Biochemical characteristics were determined
using API ZYM strips, API 50 CH strips combined with
API 50 CHB/E medium, API 20 Staph strips and ID 32
Staph strips (bioMe´rieux) according to the manufacturer’s
instructions. Additional characteristics were tested using
the Biolog system. Bacterial growth was obtained on BUG
(Biolog Universal Growth) agar+blood (Biolog) medium.
Suspension of the bacterial cells was performed using
sterile GP/GN inoculation fluid (Biolog) and samples were
dispensed to GP2 Microplates (Biolog) according to the
manufacturer’s instructions. Incubation was carried out at
36 uC in an aerobic atmosphere for 21 h.
The phenotypic characteristics of the novel strain were
compared with those of Staphylococcus piscifermentans
CIP 103958T, Staphylococcus condimenti CIP 105760T,
Staphylococcus carnosus subsp. carnosus CIP 103274T and
S. carnosus subsp. utilis CIP 105758T, which were identified
as the most closely related species by 16S rRNA gene
sequence analysis, and with those of Staphylococcus
pettenkoferi CIP 107711T and Staphylococcus chromogenes
CIP 81.59T, which were identified as the most closely
related species when tuf, rpoB, dnaJ gene sequences and
sodA gene sequences were analysed, respectively. The
distinctive traits of the novel isolate are presented in
Table 1 and Table 2. The results of additional tests are
given in the species description. Phenotypically, the most
closely related strain to strain 5402776T was S. pettenkoferi
CIP 107711T but differences were apparent for acid
production from glycerol, D-glucose, D-fructose, sucrose
and trehalose. Differences were also noted for enzymic
activities such as esterase (C4), esterase lipase (C8) and acid
phosphatase. Nitrate reduction was positive for strain
5402776T but was negative for S. pettenkoferi CIP 107711T.
Analysis of respiratory quinones by HPLC and polar lipids
by two-dimensional TLC was carried out by the DSMZ
Identification Service and Dr Brian Tindall, DSMZ,
Braunschweig, Germany. Respiratory lipoquinones were
extracted from 100 mg freeze-dried cell material as
described by Tindall (1990a, b). Respiratory lipoquinones
were separated into their different classes (menaquinones
and ubiquinones) by TLC on silica gel, using hexane : tert-
butylmethylether (9 : 1, v/v) as the solvent. UV-absorbing
bands corresponding to menaquinones or ubiquinones
were removed from the plate and further analysed by
HPLC at 269 nm. The respiratory quinones were MK-7
(93%) and MK-6 (7%). Preparation and determination of
cellular fatty acids were carried out according to the
procedures given for the Sherlock Microbial identification
system (MIDI). The major fatty acids were C15 : 0 iso
(60.5%), C17 : 0 iso (8.96%), C15 : 0 anteiso (7.93%) and
C19 : 0 iso (6.78%). The determination of the peptidoglycan
structure was carried out as described by Schleifer (1985)
and Schleifer & Kandler (1972) with the modification that
TLC on cellulose was applied instead of paper chromato-
graphy. Quantitative analysis of amino acids was per-
formed after derivatization by GC and GC/MS according to
MacKenzie (1987). The total hydrolysate (4 M HCl, 16 h,
100 uC) of the peptidoglycan contained the amino acids
lysine (Lys), alanine (Ala), glycine (Gly), serine (Ser) and
glutamic acid (Glu) in molar ratios of around
1.0 : 1.5 : 3.5 : 0.9 : 1.0. The identity of the amino acids was
confirmed by GC/MS. The partial hydrolysate (4 M HCl,
0.75 h, 100 uC) of the peptidoglycan contained (in
addition to the amino acids) the peptides L-AlaAD-Glu,
GlyAGly, GlyAL-Lys, L-LysAD-Ala and GlyAL-LysAD-
Ala. It was concluded that strain 5402776T showed the A3a
L-Lys-Gly2-3–L-Ser-Gly peptidoglycan type (type A11.3
according to http://www.dsmz.de/microorganisms/main.
php?content id535). The interpeptide bridge, consisting
of oligoglycine peptides, was characteristic of the genus
Staphylococcus. The DNA G+C content was determined by
using the HPLC method of Mesbah et al. (1989). The value
found for strain 5402776T was 36.6 mol%.
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For nucleotide sequence analysis, bacterial DNA was
extracted using the MagNA Pure LC DNA isolation kit III
(Roche) with the MagNA Pure LC instrument as described
by the manufacturer. the 16S rRNA gene was PCR-amplified
using the universal primer pair fD1 and rp2 (Weisburg et al.,
1991). The tuf, hsp60, rpoB, dnaJ and sodA genes were also
PCR-amplified as previously described (Ghebremedhin et al.,
2008; Shah et al., 2007). PCR products were purified using
the NucleoFast 96 PCR kit (Macherey–Nagel) according to
the manufacturer’s recommendations. Sequencing reactions
were carried out using the Big Dye Terminator, version 1.1,
cycle sequencing kit (Perkin-Elmer) according to the
manufacturer’s instructions. Sequencing products were
purified and sequences were analysed on an ABI PRISM
3130x Genetic Analyzer (Applied Biosystems). The sequences
obtained were compared with database sequences (GenBank)
using BLAST. Gene sequences were aligned using the multi-
sequence alignment program CLUSTAL_X (1.8). Phylogenetic
relationships with closely related species were determined
using MEGA version 4 (Tamura et al., 2007). Distance
matrices were determined following the assumptions
described by Kimura (1980) and were used to elaborate
dendrograms using the neighbour-joining method (Saitou &
Nei, 1987). The maximum-parsimony algorithm was also
used to infer phylogenetic relationships. A bootstrap analysis
was performed to investigate the stability of the tree obtained.
Bootstrap values were obtained for a consensus tree based on
100 randomly generated trees. The tree topology was the
same with the two methods.
Based on 16S rRNA sequence comparisons, a value¡97%
has been suggested as the threshold to separate species
(Stackebrandt et al., 2002). However, increasingly, novel
species have been described with higher similarity values
(Kuisiene et al., 2008; Mun et al., 2008; Song et al., 2007;
Zhou et al., 2008) and recently Stackebrandt & Ebers
Table 1. Characteristics that differentiate the novel strain from the different species tested in this study
Taxa: 1, strain 5402776T; 2, S. pettenkoferi CIP 107711T; 3, S. chromogenes CIP 81.59T; 4, S. piscifermentans CIP 103958T; 5, S. condimenti CIP
105760T; 6, S. carnosus subsp. carnosus CIP 103274T; 7, S. carnosus subsp. utilis CIP 105758T. +, Positive; 2, negative; W, weakly positive.
1 2 3 4 5 6 7
Characteristic 24 h 48 h 24 h 48 h 24 h 48 h 24 h 48 h 24 h 48 h 24 h 48 h 24 h 48 h
Acid production from (API 50 CH):
N-Acetylglucosamine 2 2 2 2 W + + + + + + + W +
Aesculin 2 2 2 2 2 2 + + 2 2 2 2 2 2
Arbutin 2 2 2 2 2 2 W + 2 2 2 2 2 2
D-Fructose 2 2 W + + + 2 + + + + + + +
D-Galactose 2 2 2 2 + + + + W + W + 2 2
D-Glucose 2 2 W + + + + + + + + + + +
Glycerol 2 2 2 W W + 2 2 2 2 W + 2 2
D-Lactose 2 2 2 2 + + + + + + + + 2 2
Maltose 2 2 2 2 2 2 + + 2 2 2 2 2 2
D-Mannitol 2 2 2 2 2 2 2 2 W + + + 2 2
D-Mannose 2 2 2 2 + + 2 2 + + + + 2 2
Melezitose 2 2 2 2 2 2 + + 2 2 2 2 2 2
D-Ribose 2 2 2 2 + + 2 2 2 + 2 2 2 2
D-Sorbitol 2 2 2 2 2 2 2 2 W + W + 2 2
Sucrose 2 2 2 W + + + + 2 2 2 2 2 2
Trehalose 2 2 2 W + + + + + + + + + +
Turanose 2 2 2 2 2 2 W + 2 2 2 2 2 2
Enzyme activities:
Acid phosphatase 2 + + + + + +
Alkaline phosphatase 2 2 + 2 + + 2
Arginine dihydrolase 2 2 + + + + +
Esterase (C4) W + + + + + +
Esterase lipase (C8) W + W + + + 2
b-Galactosidase 2 2 2 + + + 2
a-Glucosidase 2 2 2 + 2 2 +
b-Glucosidase 2 2 2 + 2 2 2
Naphthol-AS-BI-
phosphohydrolase
2 2 2 2 2 + W
Urease 2 2 2 + + 2 2
Resistance to novobiocin 2 2 2 + + + +
Nitrate reduction + 2 + + + + +
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(2006) proposed that a cut-off value of 98.7% should be
applied to define novel species on the basis of 16S rRNA
gene sequence comparisons. This new cut-off value was
confirmed by Achtman & Wagner (2008). Based on 16S
rRNA gene sequence similarity (calculated with MEGA
version 4), the highest value between the novel strain and
other species of the genus Staphylococcus was 97.7% with S.
piscifermentans. The similarity values between the novel
strain and recognized species of the genus Staphylococcus
ranged from 99.9% to 95.8% (median value, 97.3%).
Based on 16S rRNA gene sequence comparisons, strain
5402776T represented a novel species of the genus
Staphylococcus (Fig. 1). In the phylogenetic analyses
inferred from tuf, dnaJ and rpoB gene sequence compar-
isons, strain 5402776T clustered with S. pettenkoferi (see
Supplementary Figs S1, S2 and S3 in IJSEM Online). The
sequence similarity values were 93.7%, 82.5% and 89%,
respectively. In the phylogenetic analysis inferred from
sodA gene sequences, strain 5402776T clustered with S.
chromogenes (82.8%) and in the phylogenetic analysis
inferred from the hsp60 gene sequences, strain 5402776T
formed a distinct subline within the genus Staphylococcus
(see Supplementary Figs S4 and S5).
Based on the results described above, we suggest that the
novel strain isolated from a human brain abscess represents
a novel species of the genus Staphylococcus species, for
which the name Staphylococcus massiliensis sp. nov. is
proposed.
Description of Staphylococcus
massiliensis sp. nov.
Staphylococcus massiliensis (mas.si.li.en9sis. L. masc. adj.
massiliensis of Massilia, the old Roman name for Marseille,
from where the type strain was isolated).
Cells are Gram-positive, 0.5–0.8 mm in diameter, non-
spore-forming, non-motile and occur singly, in pairs and in
clusters. Growth occurs preferentially in aerobic atmos-
pheres. After 48 h on 5% sheep blood agar, colonies are
white, glossy, circular, regular, bulged, non-haemolytic
and 1–3 mm in diameter. The temperature range for
growth is 25–45 uC, with optimum growth between 30 uC
and 37 uC. Grows at 37 uC in TSB containing 0–15% (w/v)
NaCl. Coagulase-negative, catalase-positive, oxidase-negative,
novobiocin-susceptible and negative in tests for the presence
of clumping factor. Using API ZYM, activities of esterase (C4)
and esterase lipase (C8) are weakly positive. No activities for
alkaline phosphatase, lipase (C14), acid phosphatase, b-
galactosidase, leucine arylamidase, valine arylaminidase,
a-glucosidase, cystine arylaminidase, trypsin, a-chymotrypsin,
naphthol-AS-BI-phosphohydrolase, a-galactosidase, b-glu-
curonidase, b-glucosidase, N-acetyl-b-glucosaminidase, a-
mannosidase or a-fucosidase are detected. Using the API
Rapid ID32 Staph system, reduction of nitrates is positive.
No activities for urease, arginine dihydrolase, ornithine
decarboxylase, b-galactosidase, arginine arylamidase, alkaline
phosphatase, pyrrolidonyl arylamidase or b-glucuronidase.
Negative results for aesculin hydrolysis and acetoin produc-
tion. All reactions for fermentation of sugars are negative:
D-glucose, D-fructose, D-mannose, D-lactose, trehalose, D-
mannitol, raffinose, D-ribose, cellobiose, D-sucrose, turanose,
N-acetylglucosamine and L-arabinose. Using API 50 CH after
an incubation time of 48 h, acid is not produced from D-
Table 2. GP2 MicroPlate results
Taxa: 1, strain 5402776T; 2, S. pettenkoferi CIP 107711T; 3, S.
chromogenes CIP 81.59T; 4, S. piscifermentans CIP 103958T; 5, S.
condimenti CIP 105760T; 6, S. carnosus subsp. carnosus CIP 103274T;
7, S. carnosus subsp. utilis CIP 105758T. +, Positive; 2, negative; W,
weakly positive; V, variable.
Characteristic 1 2 3 4 5 6 7
Acetic acid – – – – – – +
N-Acetyl-D-glucosamine – – – – – + +
Adenosine + – – + – + +
Adenosine 59-monophosphate – – – – – + –
L-Alaninamide V – – – – – –
D-Alanine – – – + + V +
L-Alanyl glycine – – – + – – +
L-Arabinose W – – – – – +
D-Arabitol – – – + – – –
29-Deoxyadenosine + – – + – + +
Dextrin – – – + + + +
D-Fructose 6-phosphate – + – – – – –
D-Fructose – – + + + + +
D-Galactose – – – + V – –
D-Gluconic acid – – – + + + –
D-Glucose 6-phosphate – + – – – – –
L-Glutamic acid + + – + + – +
DL-a-Glycerol phosphate – – – + + – –
a-Hydroxybutyric acid – – + – – – +
c-Hydroxybutyric acid – – – V – – –
Inosine W – – – – + +
a-Ketovaleric acid + + + + W + +
D-Lactic acid methyl ester – – – – V – –
Maltose – – – + – – –
Maltotriose – – – + – – –
D-Mannitol – – – – – + –
D-Mannose – – + – + + –
Melezitose – – – + – – –
b-Methyl D-glucoside – – + – – – –
3-Methyl D-glucose – – – – + + +
D-Psicose – – + + + + +
L-Pyroglutamic acid + – – + – V –
D-Ribose + – + + + + +
L-Serine + – + + + + +
Sucrose – + + + – – –
Thymidine – – – + + + +
Thymidine 59-monophosphate – – – – V + –
Trehalose – + + + + + +
Turanose – – – + – – V
Tween 40 – – – – – – +
Uridine – – – + + + +
Uridine 59-monophosphate – – – – + + –
D-Xylose – – + – – – +
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galactose, D-glucose, D-fructose, maltose, D-lactose, sucrose,
trehalose, D-xylose, melezitose, turanose, D-lyxose, D-ribose,
D-mannose, glycerol, erythritol, D-arabinose, L-arabinose,
L-xylose, D-adonitol, methyl b-D-xylopyranoside, L-sorbose,
L-rhamnose, dulcitol, inositol, D-mannitol, D-sorbitol, methyl
a-D-mannopyranoside, methyl a-D-glucopyranoside, N-
acetylglucosamine, amygdalin, arbutin, aesculin ferric citrate,
salicin, cellobiose, D-melibiose, inulin, raffinose, starch,
glycogen, xylitol, gentiobiose, D-tagatose, D-fucose, L-fucose,
D-arabitol, L-arabitol, potassium gluconate, potassium 2-
ketogluconate or potassium 5-ketogluconate. Using the
Biolog GP2 Microplate, the following tests are positive, a-D-
glucose, D-ribose, a-ketovaleric acid, L-lactic acid, pyruvic
acid methyl ester, pyruvic acid, L-alanine, L-glutamic acid, L-
pyroglutamic acid, L-serine, glycerol, adenosine and 29-
deoxyadenosine. L-Arabinose and inosine are weakly posi-
Fig. 1. Phylogenetic tree inferred from 16S rRNA gene sequence comparisons (1264 nt fragment). Numbers at nodes are the
percentages of 100 resamplings that support the shown topology. Macrococcus bovicus, Gemella morbillorum and
Streptococcus pneumoniae were used as the outgroup. Bootstrap values .50% are indicated at nodes. Bar, 0.02 nucleotide
changes per nucleotide position.
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tive. L-Alaninamide is variable. The following tests are nega-
tive: a-cyclodextrin, b-cyclodextrin, dextrin, glycogen, inulin,
mannan, Tween 40, Tween 80, N-acetyl-D-glucosamine,
N-acetyl-b-D-mannosamine, amygdalin, D-arabitol, arbutin,
cellobiose, D-fructose, L-fucose, D-galactose, D-galacturonic
acid, gentiobiose, D-gluconic acid, myo-inositol, a-D-lactose,
lactulose, maltose, maltotriose, D-mannitol, D-mannose,
melezitose, melibiose, methyl a-D-galactoside, methyl b-D-
galactoside, 3-methyl D-glucose, methyl a-D-glucoside,
methyl b-D-glucoside, methyl a-D-mannoside, palatinose,
D-psicose, raffinose, L-rhamnose, salicin, sedoheptulosan, D-
sorbitol, stachyose, sucrose, D-tagatose, trehalose, turanose,
xylitol, D-xylose, acetic acid, a-hydroxybutyric acid, b-
hydroxybutyric acid, c-hydroxybutyric acid, p-hydroxyphe-
nylacetic acid, a-ketoglutaric acid, lactamide, D-lactic acid
methyl ester, D-malic acid, L-malic acid, succinic acid
monomethyl ester, propionic acid, succinamic acid, succinic
acid, N-acetyl-L-glutamic acid, D-alanine, L-alanyl glycine, L-
asparagine, glycyl L-glutamic acid, putrescine, 2,3-butane-
diol, thymidine, uridine, adenosine 59-monophosphate,
thymidine 59-monophosphate, uridine 59-monopho-
sphate, D-fructose 6-phosphate, a-D-glucose 1-phosphate,
D-glucose 6-phosphate and DL-a-glycerol phosphate. The
respiratory quinones are MK-7 (93%) and MK-6 (7%),
and the major fatty acids are C15 : 0 iso, C17 : 0 iso, C15 : 0
anteiso and C19 : 0 iso. The peptidoglycan type is A3a
L-Lys-Gly2-3–L-Ser-Gly.
The type strain, 5402776T (5CCUG 55927T5CSUR P23T),
was isolated from a human brain abscess. The DNA G+C
content of the type strain was 36.6 mol%.
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Preamble 
 
M. hominis is a fastidious and slow growing bacterium, commensal 
of the genito-urinary tract of healthy adults. It mostly causes urogenital 
infections but may also cause extra-genital infections [40, 41]. Infections 
caused by Mycoplasma sp. require a specific antibiotic treatment [42]. In 
addition, this bacterium cannot be Gram-stained and requires specific 
culture media. Host predisposing factors such as immunosuppression, 
malignancy, trauma, and manipulation or surgery of the genitourinary tract 
are considered as risk factors of extra-genital infections.  
M. hominis has been reported in only six patients as a cause of brain 
abscess [43-48]. In this study, we describe a case of M. hominis brain 
abscess in a female patient following uterus curettage. Bacterial culture and 
Gram-staining remained negative. M. hominis was only detected using 16S 
rDNA amplification and sequencing. In order to determine whether the 
infection was monomicrobial or polymicrobial, the PCR amplicon was 
subsequently cloned and one hundred clones were analyzed by sequencing. 
Only 16S rDNA from M. hominis was detected in the 100 clones. 
In addition, in an effort to reduce the diagnostic delay, we developed 
a specific RT-PCR for M. hominis. This test provides a rapid alternative not 
only to culture but also to broad-range 16S rDNA PCR and sequencing 
detection, and may enable rapid antibiotic treatment adaptation. 
Our data suggest that M. hominis should be suspected in patients 
developing brain abscess following genitourinary tract invasive procedures, 
notably uterine curettage. To facilitate the detection of this agent, we 
developed an accurate, sensitive, and specific RT-PCR assay for                       
M. hominis that may enable the diagnosis to be obtained within one hour 
after DNA extraction. 
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Abstract  
 
Introduction 
Mycoplasma hominis is mostly known for causing urogenital infections. 
However, it has rarely been described as an agent of brain abscess. 
 
Case Presentation 
We describe a case of M. hominis brain abscess in a female patient 
following uterus curettage. The diagnosis was obtained by 16S rDNA 
amplification, cloning and sequencing from the abscess pus, and confirmed 
by a specifically-designed real-time PCR assay. 
 
Conclusion 
Our case suggests that M. hominis should be considered as a potential agent 
of brain abscess, especially following uterine manipulation. 
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Introduction 
 Brain abscess is a life-threatening condition resulting from the 
invasion of brain tissues by microorganisms. Current microbiological 
documentation, mostly based on direct examination and culture of pus 
specimens, may underestimate the role of fastidious microorganisms in 
brain abscess (1). Among these, Mycoplasma hominis has rarely been 
reported (3,5,10,18,19,23). M. hominis is a fastidious and slow growing 
bacterium, commensal of the genito-urinary tract of healthy adults. It 
mostly causes urogenital infections but may also cause extra-genital 
infections (15,21). Infections caused by Mycoplasma sp. require a specific 
antibiotic treatment. Lacking a cell wall and folic acid synthesis, they are 
resistant to antibiotics that target cell wall or folic acid synthesis (14). In 
particular, they are naturally resistant to β-lactams, which in combination 
with metronidazole have been recommended as empirical treatment of 
bacterial brain abscesses (12). In contrast, M. hominis is sensitive to 
antibiotics that prevent the synthesis of proteins, including tetracyclines 
(16). In addition, this bacterium cannot be Gram-stained and requires 
specific culture media. However, molecular methods were successfully 
used to detect M. hominis from human samples (9). 
 
Case presentation 
 In 2006, a previously healthy, 41-year-old Caucasian pregnant 
woman was admitted to hospital in Marseilles, France, with vertigo, severe 
headache, and left hemiparesis. She had no medical history except two 
previous normal pregnancies and deliveries. A computerized-tomography 
(CT) scan and Magnetic resonance imaging (MRI) of the brain identified a 
right fronto-parietal hematoma. The hematoma was surgically-drained. Ten 
days later, at 26 weeks of gestation, the patient underwent early 
spontaneous miscarriage, which required an uterus curettage and was 
complicated by important metrorrhagia. Three days following the 
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miscarriage, the patient developed obnubilation, and subsequently coma. 
New cerebral CT and MRI revealed a fronto-parietal brain abscess. The 
abscess was surgically-removed, and purulent material was sent to our 
laboratory. A nosocomial infection being suspected, an intravenous 
empirical treatment associating vancomycin (2g / day) and meropeneme 
(6g / day) was started. Gram staining of the abscess specimen showed 
numerous polymorphonuclear leukocytes but no microorganism. The 
specimen was then plated onto 5% sheep blood agar and chocolate agar 
(BioMérieux, Marcy L’Etoile, France) and incubated at 37 °C under 
aerobic, anaerobic, and microaerophilic conditions for 10 days. Plates were 
examined daily but no growth was observed. For molecular detection, 
DNA was extracted from the pus sample using the MagNA Pure LC DNA 
isolation kit II and the MagNA Pure LC instrument as recommended by the 
manufacturer (Roche, Meylan, France). Amplification and sequencing of 
the 16S rDNA gene were performed using broad range primers as 
previously described (4). By comparison with GenBank, the sequence 
obtained from the PCR product (1,475 bp) was 100 % similar to that of              
M. hominis (Genbank accession number AF443616). As a consequence, the 
antibiotic treatment was changed to doxycycline, 200 mg per day for                 
12 weeks. The patient recovered rapidly. On follow-up, she remained 
asymptomatic 6 months after discontinuation of antibiotics. In order to 
determine whether the infection was monomicrobial or polymicrobial, the 
PCR amplicon was subsequently cloned into Escherichia coli using the 
pGEM-T Easy Vector System (Promega, Charbonnières, France). One 
hundred clones were analyzed by sequencing. Only 16S rDNA from                    
M. hominis was detected in the 100 clones. The identification of                         
M. hominis in our patient and the previously published cases motivated the 
development of a specific real time-PCR (RT-PCR) assay for this 
bacterium. 16S rDNA was selected as target. Using the Primer Express 
software (Applied Biosystem), specific primers and probes were designed 
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as follows: MHMGB16Sd (5’-TGT TAT AAG GGA AGA ACA TTT 
GCA AT-3’), MHMGB16Sr (5’-GCC ATC GCT TTC TGA CAA GG-3’) 
and MHMGB16S probe (FAM-AAA-TGA-TTG-CAG-ACT-GAC-MGB) 
respectively. RT- PCR was performed using a LightCycler (Roche). The 
PCR mix consisted of 4 µl of pus DNA, 10 µl of Quantitect Probe PCR 
Master Mix (Qiagen, Courtaboeuf, France), 20 pMol of each primer 
(Eurogentec, Seraing, Belgium), 0.5 µl of Uracil DNA glycosylase 
(Invitrogen), 0.5 µl of 3.125 µM MHMGB probe (Applera), and 4 µl of 
water. DNA was amplified using the following cycling parameters: heating 
at 50 °C for 2 min, and then at 95 °C for 15 min, followed by 50 cycles of a 
two-stage temperature profile of 95 °C for 1 s and 60 °C for 45 s. The 
specificity of the primers and probes was tested using BLAST 
(http://blast.ncbi.nlm.nih.gov/) and by tentatively amplifying DNA from  
24 distinct Mycoplasma species. The system was found to be M. hominis-
specific, as no amplification was obtained from any other mycoplasmal or 
human DNA. For our patient, positive amplification was obtained after              
22 PCR cycles. Negative controls remained negative. 
 
Discussion 
 M. hominis frequently colonizes the lower genitourinary tract of 
women (13). Host predisposing factors such as immunosuppression, 
malignancy, trauma, and manipulation or surgery of the genitourinary tract 
are considered as risk factors of extra-genital infections. It was notably 
demonstrated that blood spread of mycoplasmas may follow urinary tract 
catheterization or lithiasis (20). To the best of our knowledge, M. hominis 
has been reported in only six patients as a cause of brain abscess 
(3,5,10,18,19,23) (Table 1). In the three female patients, M. hominis 
infection complicated a traumatic or spontaneous brain hematoma in a 
context of normal vaginal or cesarean delivery (3,5,23). In the two male 
adult patients, the M. hominis infection complicated a head trauma in the 
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context of urinary tract catheterization (10,18). In female patients, the most 
likely source of M. hominis was the genitourinary tract whereas it was the 
genito-urinary tract in men. The latest patient, a 3-week-old baby most 
likely acquired the M. hominis infection from passage through the maternal 
birth canal (19). In our patient, we assume that the source of infection was 
the genital tract, as the patient underwent uterine curettage. It should be 
noted that in most cases, M. hominis superinfected a brain hematoma.                
By searching the literature for other cases of M. hominis infection of 
hematomas, we found six articles describing patients who had developed 
infection of abdominal, perinephric, thigh or retroperitoneal hematomas 
following genitourinary invasive procedures (2,7,8,11,17,22) (Table 2). In 
an additional patient, infection complicated a perihepatic hematoma but the 
origin of infection was not identified (6). Therefore, our study strongly 
suggests that M. hominis has a particular ability for superinfecting 
hematomas, in particular following genitourinary tract invasive procedures. 
 In addition, as previously reported (10), bacterial culture and Gram-
staining remained negative. M. hominis was only detected by PCR. In 
addition, in an effort to reduce the diagnostic delay, we developed a 
specific RT-PCR for M. hominis. This test provides a rapid alternative not 
only to culture but also to broad-range 16S rRNA PCR and sequencing 
detection, and may enable rapid antibiotic treatment adaptation. 
 
Conclusion 
 Our data suggest that M. hominis should be suspected in patients 
developing brain abscess following genitourinary tract invasive procedures, 
notably uterine curettage. To facilitate the detection of this agent, we 
developed an accurate, sensitive, and specific RT-PCR assay for                          
M. hominis that may enable the diagnosis to be obtained within one hour 
after DNA extraction. 
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Table 1: Epidemio-clinical features of previously reported patients with  
M. hominis brain abscess.     
 
Sex / age Medical history Identification  Reference 
M / 29 Traumatic brain hematoma 
and urinary tract 
catheterization 
Culture (18) 
M / 40 Head trauma and urinary 
tract catheterization 
 
PCR 
(10) 
F / 22 Brain hematoma following 
normal vaginal delivery  
Culture (23) 
F / 17 Subdural hematoma 
following normal full term 
pregnancy and delivery 
 
Culture  
 
(3) 
F / 32 Subdural hematoma 
following caesarean delivery 
Culture (5) 
M /3 
week 
Normal full term pregnancy 
and delivery  
PCR (19) 
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Table 2: Cases of hematoma (other than brain) infected with Mycoplasma 
hominis. 
 
Sex / 
age 
history Identification Reference 
F / 27 Abdominal hematoma 
following cesarean section 
Culture (8) 
F / 27 Abdominal hematoma 
following cesarean section 
Culture + 
PCR 
(22) 
M / 74 Wound and perinephric 
haematoma following renal 
transplantation  
Culture (17) 
F / 18 Perinephric hematoma 
following renal 
transplantation 
Culture (11) 
F / 36 Thigh hematoma following 
trauma of pelvis and 
genitourinary tract 
Culture  (7) 
M / 55 Perihepatic hematoma 
following liver transplantation  
Culture (6) 
M / 29 Retroperitoneal hematoma 
following pelvis trauma 
Culture (2) 
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Preamble 
 
Nocardia species are soil saprophytic and filamentous bacteria from 
the Actinomycetales order. In humans, several Nocardia species have been 
described as opportunistic bacteria infecting immunocompromised patients 
[49]. In organ transplant recipients, Nocardia species are well known 
agents of opportunistic infections [50], in particular, brain abscesses                
[51, 52]. In Australia, Nocardia species were identified in 8.5% of brain 
abscesses of organ transplant recipients [50].Although most cases are due 
to N. asteroides, other species have been reported, including N. farcinica, 
N. brasiliensis, N. nova, N. transvalensis, and N. otitidiscaviarum. 
In the current study, we report the first case of N. carnea brain 
abscess in a kidney transplant recipient. Our case was confirmed by 
molecular detection despite negative cultures.  
Our report highlights the putative role of N. carnea as agent of brain 
abscess infection in a kidney transplant recipient. The originality of this 
infection, in addition to the unusual causative species, was its late 
occurrence, more than 5 years after transplantation.  
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Abstract 
 
We report an unusual case of Nocardia carnea brain and lung 
abscesses in a kidney transplant recipient. Our case was confirmed by 
molecular detection despite negative cultures. The patient recovered using 
a prolonged cotrimoxazole treatment. 
 
Text 
On November 10
th
, 2008, a 54-year-old man was admitted to the 
Nephrology department of the Conception Hospital in Marseille, France, 
for investigation of a left lung opacity diagnosed on a chest X-ray. 
Symptoms had started on October 19
th
, 2008, with isolated fever, initially 
regressive under amoxicillin-clavulanate. The patient had a history of adult 
hepatic and renal polycystosis, and was followed since 1999 in the 
Nephrology department for chronic renal failure. He was treated by chronic 
haemodialysis until April 12
th
, 2003, when he underwent cadaveric kidney 
allograft transplantation. Postoperatively, his renal function was stable, 
with an average serum creatinin level of 120 µmol/l under an 
immunosuppressive regimen of ciclosporin and prednisone. His treatment 
also included acetylsalicylate, 100 mg/d, atorvastatin, 40 mg/d, amlodipin, 
5 mg/d, and rilmenidin, 1 mg/d. Since transplantation, he had developed 
several urinary tract infections, mainly due to Staphylococcus species and 
Enterobacter cloacae. The course was also remarkable for surgical 
complications, including an episode of diverticular sigmoiditis, 
appendectomy, ureteric reimplantation in the early post-transplantation 
period, and cure of abdominal aortic aneurysm in November 2007. 
 On admission, the physical examination revealed a physically fit 
male in no acute distress. His body temperature was 37.6°C, his blood 
pressure was 130/80 mm Hg, his pulse was regular at 90 bpm; his heart 
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sounds were normal. The patient’s respiration was unlabored, at                   
16 breaths/mn. His lungs were clear to auscultation. The clinical 
examination was otherwise normal. Laboratory tests showed a leukocyte 
count of 4.89x10
9
/l with 79% polymorphonuclears, and a haemoglobin 
level of 95 g/l. Liver functional tests were within normal range and serum 
creatinin was 114µmol/l. Urine culture was sterile. A thoracic computed 
tomodensitometry (CT) showed a large left apical lesion that was suspected 
to be of neoplasic origin. A brain CT detected two occipital lesions with 
peripheral reinforcement that were compatible with brain abscessses 
(Figure 1). Brain resonance magnetic imaging ruled out metastases. A 
bronchoscopy yielded biopsy samples for culture and molecular detection. 
Three guided brain abscess biopsies were also performed. Usual culture of 
all specimens remained negative after 3 weeks of incubation on 5% sheep 
blood agar in a 5% CO2 atmosphere at 37°C. In contrast, amplification and 
sequencing of the 16S rRNA, as previously described 
1
, identified Nocardia 
carnea (N. carnea), with a 100% nucleotide sequence similarity with the 
GenBank entry AF430035 in all lung and brain biopsies. The patient was 
then treated with an association of intravenous imipenem, 2 g/d, and oral 
cotrimoxazole, 2,400 mg/d for one month, and then cotrimoxazole only, for 
one year. Subsequently, he remained well and brain and lung lesions 
disappeared within 9 months as assessed by repeated thoracic and brain 
CTs. 
To the best of our knowledge, we herein report the first case of                 
N. carnea brain abscess in a kidney transplant recipient. Our case was 
confirmed by molecular detection despite negative cultures. Nocardia 
species are soil saprophytic and filamentous bacteria from the 
Actinomycetales order. In humans, several Nocardia species have been 
described as opportunistic bacteria infecting immunocompromised 
patients
2
. They may cause localized or disseminated infections 
2
. Infections 
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most often develop initially in lungs and may subsequently lead to 
bloodstream infections with secondary locations 
2
. Tomodensitometry 
usually shows necrotic lesions with peripheral enhancement, and MRI may 
provide a differential diagnosis with tumors. These infections mostly 
evolve on a chronic mode. Due to the absence of pathognomonic clinical 
signs, the diagnosis is often delayed. The diagnosis of nocardiosis is 
currently based on direct examination and conventional cultures, but 
molecular detection tools have proven useful both for detection and species 
identification 
3, 4
.  
Renal transplant recipients are susceptible to a large panel of 
infectious agents. In addition, due to immunosuppression, their 
inflammatory response is impaired, making patients minimally 
symptomatic. However, the infectious risk may vary over time. In the first 
month following transplantation, they are mostly exposed to postoperative 
infections (bacterial and fungal agents) and to donor or recipient-derived 
infections that had not been eradicated (or detected) before transplantation. 
Between one and six months after surgery, infections are mostly viral 
(CMV, HSV, VZV, HHV6, EBV, HBV, HCV, respiratory viruses,                    
BK polyomavirus), but other infectious agents may be encountered, 
including Listeria monocytogenes, Mycobacterium tuberculosis, Nocardia 
species, Pneumocystis jiroveci (carinii), Toxoplasma gondii, Aspergillus 
sp., Cryptococcus sp., Strongyloides sp. Later, most patients have stable 
allograft function and minimal immunosuppressive therapy, and infections 
are usually similar to the general population. In some cases, patients suffer 
chronic viral infections, including CMV chorioretinitis, 
lymphoproliferative disorders due to EBV, chronic hepatitis,                        
BK polyomavirus nephropathy, skin or anogenital cancer caused by 
papillomavirus 
5
. 
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In organ transplant recipients, Nocardia species are well known 
agents of opportunistic infections 
6
, in particular, brain abscesses 
5, 7
. In 
Australia, Nocardia species were identified in 8.5% of brain abscesses of 
organ transplant recipients 
6
. Although most cases are due to N. asteroides, 
other species have been reported, including N. farcinica, N. brasiliensis,             
N. nova, N. transvalensis, and N. otitidiscaviarum. N. carnea was first 
described in 1891 under the name Streptothrix carnea 
8
. In 1985, Akgun et 
al. reported a case of multiple cutaneous abscesses of the leg and the supra-
clavicular region in a kidney transplant recipient woman 
9
. In a review of 
Nocardia infections in France from 1987 to 1990, of 63 clinical isolates, a 
case of N. carnea (1.5%) was noted in an immunocompetent man 
10
. In 
2005, a case of N carnea pneumonia was reported in an 58-year-old man 
treated with corticosteroids 
3
. In 2006, N. carnea was isolated in a 84 year 
old man with tuberculosis and bronchiectasis 
11
. The treatment of choice for 
Nocardia infections uses cotrimoxazole, however they are usually sensitive 
to imipenem, amikacin, minocycline and C3G 
12
. Our patient recovered 
using prolonged cotrimoxazole treatment initially associated to imipenem. 
Our report highlights the putative role of N. carnea as agent of brain 
abscess infection in a kidney transplant recipient. The originality of this 
infection, in addition to the unusual causative species, was its late 
occurrence, more than 5 years after transplantation. 
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Figure 1: Brain computerized tomodensitometry showing a left occipital 
lesion with surrounding edema.  
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CONCLUSIONS AND PERSPECTIVES 
 
Brain abscess is a life-threatening infection with a high mortality and 
frequent serious sequelae. To reduce the mortality and sequelae, rapid and 
accurate diagnosis and treatment are required. The microbial flora of brain 
abscesses is far from being fully known, and is differentially distributed 
according to the abscess aetiology. Identifying the immunocompetence of 
the host and the possible source of infection may help to predict of the 
bacteria implicated in this condition.  
Microbiological documentation of brain abscess using direct 
microscopic examination and culturing of abscess pus does not reflect the 
variety of bacteria implicated. This procedure has many limitations and 
reveals only a small portion of the true microbial population. In addition, 
conventional methods for the identification and characterization of clinical 
isolates of bacterial pathogens sometimes fall short when such isolates 
exhibit unusual phenotypic profiles.  
PCR and sequencing technology offer a more rapid and accurate 
identification than that obtained with standard culture methods. PCR-
amplified 16S rDNA sequencing can be used to overcome the limitations of 
culture-based bacteria detection in brain abscess pus. Unfortunately, this 
procedure fails to discriminate among mixed flora. Thus, amplification of 
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the bacterial 16S rRNA gene followed by cloning and sequencing represent 
the best methods to resolve the limitations related to culture and direct 16S 
rRNA gene amplification and sequencing.  
Also, the combination of all these procedures may be indispensable 
to better understand the situation. However, 16S rRNA gene cloning and 
sequencing are time consuming and labor intensive. Therefore, a more 
rapid and accurate procedure may be necessary in the future to overcome 
all limitations and to improve the diagnosis of brain abscess.  
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